https://www.pharmaceutical-technology.com/data-insights/cspc-pharmaceutical-group-patent-activity/ 2024-07-21T17:01:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hikma-pharmaceuticals-patent-activity/ 2024-07-21T17:01:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hualan-biological-engineering-patent-activity/ 2024-07-21T17:00:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/yunnan-baiyao-group-patent-activity/ 2024-07-21T17:00:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zhejiang-nhu-patent-activity/ 2024-07-21T17:00:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/theravance-biopharma-patent-activity/ 2024-07-21T17:00:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/catalent-patent-activity/ 2024-07-21T17:00:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/agios-pharmaceuticals-patent-activity/ 2024-07-21T17:00:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sage-therapeutics-patent-activity/ 2024-07-21T17:00:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/codexis-patent-activity/ 2024-07-21T17:00:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/enanta-pharmaceuticals-patent-activity/ 2024-07-21T17:00:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/precigen-patent-activity/ 2024-07-21T17:00:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xenon-pharmaceuticals-patent-activity/ 2024-07-21T17:00:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abbvie-patent-activity/ 2024-07-21T17:00:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zoetis-patent-activity/ 2024-07-21T17:00:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/intra-cellular-therapies-patent-activity/ 2024-07-21T17:00:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hca-healthcare-patent-activity/ 2024-07-21T17:00:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/uniqure-patent-activity/ 2024-07-21T17:00:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xencor-patent-activity/ 2024-07-21T16:59:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ptc-therapeutics-patent-activity/ 2024-07-21T17:00:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arcturus-therapeutics-patent-activity/ 2024-07-21T16:59:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/prothena-corp-patent-activity/ 2024-07-21T16:59:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/teva-pharmaceutical-industries-patent-activity/ 2024-07-21T16:59:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jazz-pharmaceuticals-patent-activity/ 2024-07-21T16:59:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gilead-sciences-patent-activity/ 2024-07-21T16:59:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dynavax-technologies-patent-activity/ 2024-07-21T16:59:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bausch-health-patent-activity/ 2024-07-21T16:59:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/united-therapeutics-patent-activity/ 2024-07-21T16:59:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arrowhead-pharmaceuticals-patent-activity/ 2024-07-21T16:59:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/seagen-patent-activity/ 2023-12-11T01:54:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amicus-therapeutics-patent-activity/ 2024-07-21T16:59:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ionis-pharmaceuticals-patent-activity/ 2024-07-21T16:59:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vanda-pharmaceuticals-patent-activity/ 2024-07-21T16:59:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azenta-patent-activity/ 2024-07-21T16:59:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biocryst-pharmaceuticals-patent-activity/ 2024-07-21T16:59:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/regeneron-pharmaceuticals-patent-activity/ 2024-07-21T16:59:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/exelixis-patent-activity/ 2024-07-21T16:59:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/incyte-patent-activity/ 2024-07-21T16:58:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sangamo-therapeutics-patent-activity/ 2024-07-21T16:59:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biogen-patent-activity/ 2024-07-21T16:58:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sarepta-therapeutics-patent-activity/ 2024-07-21T16:58:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vertex-pharmaceuticals-patent-activity/ 2024-07-21T16:58:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inovio-pharmaceuticals-patent-activity/ 2024-07-21T16:58:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/immunogen-patent-activity/ 2024-02-22T06:56:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eli-lilly-and-co-patent-activity/ 2024-07-21T16:58:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/geron-patent-activity/ 2024-07-21T16:58:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/merck-patent-activity/ 2024-07-21T16:58:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/halozyme-therapeutics-patent-activity/ 2024-07-21T16:58:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sorrento-therapeutics-patent-activity/ 2024-07-21T16:58:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mannkind-patent-activity/ 2024-07-21T16:58:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/insmed-patent-activity/ 2024-07-21T16:58:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ligand-pharmaceuticals-patent-activity/ 2024-07-21T16:58:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alnylam-pharmaceuticals-patent-activity/ 2024-07-21T16:58:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/agenus-patent-activity/ 2024-07-21T16:58:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/corcept-therapeutics-patent-activity/ 2024-07-21T16:58:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pfizer-patent-activity/ 2024-07-21T16:58:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/viatris-patent-activity/ 2024-07-21T16:58:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/russia-investment-climate-forums-fdi-decline/ 2024-03-27T23:37:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vittorias-car-t-therapy-secures-clinical-approval-amid-fda-scrutiny-on-sector/ 2023-12-13T11:03:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accept-nextpoint-therapeutics-ind-for-hhla2-targeting-mab/ 2023-12-08T17:19:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-lays-out-plan-to-seize-govt-funded-drug-patents-to-lower-cost/ 2023-12-08T17:17:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizers-multiple-myeloma-treatment-secures-conditional-approval-in-eu/ 2023-12-08T16:05:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msds-keytruda-and-eisais-lenvima-fail-in-phase-iii-uterine-cancer-trial/ 2023-12-08T14:31:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kymeras-protein-degrader-starts-phase-ii-trial-in-atopic-dermatitis/ 2024-02-27T11:57:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vanda-acquires-actelion-drug/ 2024-01-23T10:13:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-alpha-cognition-nda/ 2023-12-08T10:46:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/artbio-art-pipeline/ 2023-12-08T08:31:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abelzeta-astrazeneca-cell-therapy/ 2023-12-13T11:02:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/calcitonin-gene-related-peptide-type-1-receptor-drugs-in-development/ 2024-10-01T02:42:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/apoptosis-regulator-bax-drugs-in-development/ 2024-10-01T02:30:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hepcidin-drugs-in-development/ 2024-10-01T02:57:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gamma-aminobutyric-acid-receptor-subunit-alpha-2-drugs-in-development/ 2024-10-01T02:54:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alpha-2c-adrenergic-receptor-drugs-in-development/ 2024-10-01T02:29:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fibroblast-growth-factor-2-drugs-in-development/ 2024-10-01T02:53:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/metabotropic-glutamate-receptor-7-drugs-in-development/ 2024-10-01T03:06:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cholesteryl-ester-transfer-protein-drugs-in-development/ 2024-10-01T02:45:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/histone-deacetylase-8-drugs-in-development/ 2024-10-01T02:57:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/protein-kinase-c-epsilon-type-drugs-in-development/ 2024-10-01T03:23:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gamma-aminobutyric-acid-receptor-subunit-alpha-3-drugs-in-development/ 2024-10-01T02:54:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/collagenase-3-drugs-in-development/ 2024-10-01T02:46:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/metabotropic-glutamate-receptor-4-drugs-in-development/ 2024-10-01T03:06:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neuropeptide-y-receptor-type-2-drugs-in-development/ 2024-10-01T03:15:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bromodomain-testis-specific-protein-drugs-in-development/ 2024-10-01T02:42:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-7-receptor-subunit-alpha-drugs-in-development/ 2024-10-01T03:03:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/procathepsin-l-drugs-in-development/ 2024-10-01T02:44:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/somatostatin-receptor-type-2-drugs-in-development/ 2024-10-01T03:45:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/histamine-h4-receptor-drugs-in-development/ 2024-10-01T02:57:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/high-mobility-group-protein-b1-drugs-in-development/ 2024-10-01T02:57:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/serine-peptidase-inhibitor-kazal-type-drugs-in-development/ 2024-10-01T03:27:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/serine-threonine-protein-kinase-pim-2-drugs-in-development/ 2024-10-01T03:28:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/smoothened-homolog-drugs-in-development/ 2024-10-01T03:29:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bcl-2-like-protein-1-drugs-in-development/ 2024-10-01T02:41:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/insulin-like-growth-factor-i-drugs-in-development/ 2024-10-01T02:59:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/plasma-kallikrein-drugs-in-development/ 2024-10-01T03:19:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/n-sulphoglucosamine-sulphohydrolase-drugs-in-development/ 2024-10-01T03:08:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/leptin-receptor-drugs-in-development/ 2024-10-01T03:04:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/growth-differentiation-factor-8-drugs-in-development/ 2024-10-01T02:56:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/serine-threonine-protein-kinase-pim-1-drugs-in-development/ 2024-10-01T03:28:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cell-division-cycle-7-related-protein-kinase-drugs-in-development/ 2024-10-01T02:45:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gamma-aminobutyric-acid-receptor-subunit-alpha-5-drugs-in-development/ 2024-10-01T02:54:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/v-type-immunoglobulin-domain-containing-suppressor-of-t-cell-activation-drugs-in-development/ 2024-10-01T03:52:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/metabotropic-glutamate-receptor-3-drugs-in-development/ 2024-10-01T03:06:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/c5a-anaphylatoxin-chemotactic-receptor-1-drugs-in-development/ 2024-10-01T02:42:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/muscarinic-acetylcholine-receptor-m2-drugs-in-development/ 2024-10-01T03:08:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bromodomain-containing-protein-3-drugs-in-development/ 2024-10-01T02:42:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bromodomain-containing-protein-2-drugs-in-development/ 2024-10-01T02:42:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alpha-n-acetylglucosaminidase-drugs-in-development/ 2024-10-01T02:29:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/superoxide-dismutase-drugs-in-development/ 2024-10-01T03:46:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/5-hydroxytryptamine-receptor-2b-drugs-in-development/ 2024-10-01T02:27:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/protein-kinase-c-beta-type-drugs-in-development/ 2024-10-01T03:23:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glycoprotein-41-drugs-in-development/ 2024-10-01T02:55:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neuronal-acetylcholine-receptor-subunit-alpha-7-drugs-in-development/ 2024-10-01T03:15:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/toll-like-receptor-2-drugs-in-development/ 2024-10-01T03:47:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nicotinamide-phosphoribosyltransferase-drugs-in-development/ 2024-10-01T03:15:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iduronate-2-sulfatase-drugs-in-development/ 2024-10-01T02:58:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/phenylalanine-4-hydroxylase-drugs-in-development/ 2024-10-01T03:18:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/histone-deacetylase-3-drugs-in-development/ 2024-10-01T02:57:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/metabotropic-glutamate-receptor-2-drugs-in-development/ 2024-10-01T03:06:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/c-c-chemokine-receptor-type-5-drugs-in-development/ 2024-10-01T02:44:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/proto-oncogene-tyrosine-protein-kinase-ros-drugs-in-development/ 2024-10-01T03:23:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/beta-nerve-growth-factor-drugs-in-development/ 2024-10-01T02:42:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/metabotropic-glutamate-receptor-5-drugs-in-development/ 2024-10-01T03:06:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/estrogen-receptor-beta-drugs-in-development/ 2024-10-01T02:52:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glycogen-synthase-kinase-3-beta-drugs-in-development/ 2024-10-01T02:55:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/matrix-metalloproteinase-9-drugs-in-development/ 2024-10-01T03:06:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glucagon-like-peptide-2-receptor-drugs-in-development/ 2024-10-01T02:55:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tyrosine-protein-kinase-lck-drugs-in-development/ 2024-10-01T03:51:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alpha-l-iduronidase-drugs-in-development/ 2024-10-01T02:29:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rac-gamma-serine-threonine-protein-kinase-drugs-in-development/ 2024-10-01T03:24:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/substance-p-receptor-drugs-in-development/ 2024-10-01T03:46:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/islet-amyloid-polypeptide-drugs-in-development/ 2024-10-01T03:03:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/frataxin-mitochondrial-drugs-in-development/ 2024-10-01T02:53:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/serine-threonine-protein-kinase-nek7-drugs-in-development/ 2024-10-01T03:27:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lysosomal-alpha-glucosidase-drugs-in-development/ 2024-10-01T03:05:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/catenin-beta-1-drugs-in-development/ 2024-10-01T02:44:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/transmembrane-protein-pvrig-drugs-in-development/ 2024-10-01T03:49:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/5-hydroxytryptamine-receptor-7-drugs-in-development/ 2024-10-01T02:27:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/retinal-specific-phospholipid-transporting-atpase-abca4-drugs-in-development/ 2024-10-01T03:25:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/retinoic-acid-receptor-beta-drugs-in-development/ 2024-10-01T03:26:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/integrin-beta-7-drugs-in-development/ 2024-10-01T02:59:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/muscarinic-acetylcholine-receptor-m4-drugs-in-development/ 2024-10-01T03:08:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/histone-deacetylase-2-drugs-in-development/ 2024-10-01T02:57:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/prostaglandin-e2-receptor-ep1-subtype-drugs-in-development/ 2024-10-01T03:22:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hexokinase-4-drugs-in-development/ 2024-10-01T02:55:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tyrosine-protein-kinase-itk-tsk-drugs-in-development/ 2024-10-01T03:51:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-1-receptor-associated-kinase-4-drugs-in-development/ 2024-10-01T03:00:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tyrosine-protein-kinase-receptor-tyro3-drugs-in-development/ 2024-10-01T03:51:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/leucine-rich-repeat-serine-threonine-protein-kinase-drugs-in-development/ 2024-10-01T03:04:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tyrosine-protein-kinase-jak1-drugs-in-development/ 2024-10-01T03:51:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/histone-deacetylase-1-drugs-in-development/ 2024-10-01T02:57:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cyclin-dependent-kinase-2-drugs-in-development/ 2024-10-01T02:47:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/toll-like-receptor-3-drugs-in-development/ 2024-10-01T03:47:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/coagulation-factor-xi-drugs-in-development/ 2024-10-01T02:46:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aryl-hydrocarbon-receptor-drugs-in-development/ 2024-10-01T02:31:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/c-c-chemokine-receptor-type-4-drugs-in-development/ 2024-10-01T02:44:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-and-arvinas-plan-vepdegestrant-programme-expansion-after-data-at-sabcs/ 2023-12-07T17:28:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sosei-wins-south-korean-approval-for-brain-injury-drug/ 2023-12-07T17:30:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-fast-tracks-solid-biosciencess-duchenne-gene-therapy/ 2023-12-13T11:02:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lts-wins-1-2m-grant-to-develop-mrna-therapy-patches/ 2023-12-07T15:07:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/strategies-and-innovations-for-reducing-drug-product-loss-in-sterile-filling/ 2025-07-03T10:06:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ipsen-and-genfit-secure-fda-priority-review-for-chronic-liver-disease-drug/ 2023-12-07T11:53:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/synplogen-ginkgo-mou-dna-manufacturing/ 2023-12-07T11:26:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japan-bms-abecma-multiple-myeloma/ 2023-12-07T10:44:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dr-reddys-coya-als-combination-therapy/ 2023-12-07T09:18:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-to-acquire-cerevel/ 2023-12-07T09:17:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/twelve-eu-states-failed-to-report-on-fdi-between-2020-and-2022/ 2024-03-27T23:37:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/igm-jettisons-workforce-and-blood-cancer-programme-to-refocus-pipeline/ 2023-12-06T18:10:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ly-3885125-eli-lilly-and-co-dyslipidemia-likelihood-of-approval/ 2024-07-05T06:21:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nitric-oxide-sanotize-research-and-development-warts-likelihood-of-approval/ 2025-01-20T16:15:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-state-of-the-clinical-trial-supply-chain-what-you-need-to-know/ 2024-02-22T14:48:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cg-oncologys-bladder-cancer-drug-gets-fast-track-to-approval/ 2023-12-06T16:32:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/host-cell-protein-analytics-what-biomanufacturers-need-to-know/ 2023-12-06T16:18:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-partners-with-bighat-to-develop-antibody-therapies/ 2023-12-06T15:14:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-partners-with-hibercell-for-phase-ib-renal-carcinoma-trial/ 2023-12-06T14:47:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-novavax-vaccine/ 2023-12-06T10:43:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/seattle-childrens-brainchild-bio-launch/ 2023-12-06T10:43:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/odyssey-therapeutics-101m-fund/ 2023-12-06T09:30:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bristol-myers-squibb-urothelial-carcinoma/ 2023-12-06T09:29:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/qa-tackling-the-rise-of-fake-anti-obesity-drugs-on-the-market/ 2023-12-06T00:40:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adr-001-rohto-pharmaceutical-iga-nephropathy-berger-s-disease-likelihood-of-approval/ 2023-12-06T03:12:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cosibelimab-checkpoint-therapeutics-metastatic-transitional-urothelial-tract-cancer-likelihood-of-approval/ 2024-09-09T04:06:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cosibelimab-checkpoint-therapeutics-malignant-pleural-mesothelioma-likelihood-of-approval/ 2024-09-09T04:06:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cosibelimab-checkpoint-therapeutics-renal-cell-carcinoma-likelihood-of-approval/ 2024-09-09T04:06:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cosibelimab-checkpoint-therapeutics-small-cell-lung-cancer-likelihood-of-approval/ 2024-09-09T04:06:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vvz-2471-vivozon-opium-opioid-addiction-likelihood-of-approval/ 2025-01-20T02:14:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vvz-2471-vivozon-depression-likelihood-of-approval/ 2025-01-20T02:14:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vvz-2471-vivozon-anxiety-disorders-likelihood-of-approval/ 2025-01-20T02:14:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/doxorubicin-shanghai-affinity-biopharmaceutical-gastric-cancer-likelihood-of-approval/ 2025-01-20T02:12:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/doxorubicin-shanghai-affinity-biopharmaceutical-ovarian-cancer-likelihood-of-approval/ 2025-01-20T02:12:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/doxorubicin-shanghai-affinity-biopharmaceutical-breast-cancer-likelihood-of-approval/ 2025-01-20T02:11:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cbp-1008-coherent-biopharma-breast-cancer-likelihood-of-approval/ 2024-07-05T06:11:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cobolimab-gsk-melanoma-likelihood-of-approval/ 2025-01-20T02:11:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lisocabtagene-maraleucel-bristol-myers-squibb-primary-cns-lymphoma-likelihood-of-approval/ 2025-01-20T02:11:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/linvoseltamab-regeneron-pharmaceuticals-multiple-myeloma-kahler-disease-likelihood-of-approval/ 2025-01-19T18:26:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gepotidacin-mesylate-gsk-uncomplicated-cervical-and-urethral-gonorrhea-likelihood-of-approval/ 2025-01-19T18:25:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sct-200-sinocelltech-group-metastatic-colorectal-cancer-likelihood-of-approval/ 2025-01-19T18:22:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lisocabtagene-maraleucel-bristol-myers-squibb-splenic-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2025-01-19T18:21:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lisocabtagene-maraleucel-bristol-myers-squibb-extranodal-marginal-zone-b-cell-lymphoma-mucosa-associated-lymphoid-tissue-or-malt-lymphoma-likelihood-of-approval/ 2025-01-19T18:21:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lisocabtagene-maraleucel-bristol-myers-squibb-nodal-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2025-01-19T18:21:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cbp-1008-coherent-biopharma-human-epidermal-growth-factor-receptor-2-positive-breast-cancer-her2-breast-cancer-likelihood-of-approval/ 2024-07-05T05:59:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cobolimab-gsk-hepatocellular-carcinoma-likelihood-of-approval/ 2025-01-19T18:19:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zed-1227-zedira-celiac-disease-likelihood-of-approval/ 2025-01-19T18:13:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/iberdrola-masdar-co-invest-15-billion-euros-europe-us/ 2024-03-27T23:37:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uzbekistan-fdi-hits-7-5bn-in-first-nine-months-of-2023/ 2024-03-27T23:37:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/opinion/germanys-cop28-message-is-undermined-by-its-domestic-climate-action-crisis/ 2023-12-05T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pacmilimab-cytomx-therapeutics-thymic-carcinoma-likelihood-of-approval/ 2024-07-05T05:52:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pacmilimab-cytomx-therapeutics-small-intestine-cancer-likelihood-of-approval/ 2025-01-19T18:13:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pacmilimab-cytomx-therapeutics-salivary-gland-cancer-likelihood-of-approval/ 2025-01-19T18:12:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ipilimumab-bristol-myers-squibb-soft-tissue-sarcoma-likelihood-of-approval/ 2025-01-19T18:08:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tlc-6740-orsobio-insulin-resistance-likelihood-of-approval/ 2025-01-19T18:07:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tlc-6740-orsobio-obesity-likelihood-of-approval/ 2025-01-19T18:07:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/immunogens-adc-elahere-wins-fda-priority-review-for-ovarian-cancer/ 2023-12-05T17:18:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ninerafaxstat-imbria-pharmaceuticals-coronary-artery-disease-cad-ischemic-heart-disease-likelihood-of-approval/ 2024-07-05T05:20:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/radius-health-patent-activity/ 2024-07-21T16:57:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/intron-biotechnology-patent-activity/ 2024-07-21T16:57:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/beigene-patent-activity/ 2024-07-21T16:57:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/macrogenics-patent-activity/ 2024-07-21T16:57:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/4d-molecular-therapeutics-patent-activity/ 2024-07-21T16:57:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gsk-patent-activity/ 2024-07-21T16:57:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rigel-pharmaceuticals-patent-activity/ 2024-07-21T16:57:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sutro-biopharma-patent-activity/ 2024-07-21T16:57:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/prelude-therapeutics-patent-activity/ 2024-07-21T16:57:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/atreca-patent-activity/ 2024-07-21T16:57:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/molecular-templates-patent-activity/ 2024-07-21T16:57:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chong-kun-dang-patent-activity/ 2024-07-21T16:57:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kolmar-korea-patent-activity/ 2024-02-22T06:55:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jinyu-bio-technology-patent-activity/ 2024-07-21T16:57:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/voyager-therapeutics-patent-activity/ 2024-07-21T16:57:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/crispr-therapeutics-ventures-into-autoimmune-disorder-car-t-development/ 2023-12-05T16:34:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innate-pharma-patent-activity/ 2024-07-21T16:57:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innocare-pharma-patent-activity/ 2024-07-21T16:57:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-signs-140m-small-molecule-discovery-deal-with-aqemia/ 2023-12-05T16:01:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/emirati-oil-casts-an-inescapable-shadow-over-climate-talks-at-cop28/ 2023-12-05T16:19:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/travere-downsizes-after-a-failed-bid-for-filspari-label-expansion/ 2023-12-05T17:26:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cto-europe-2023-a-snapshot-of-challenges-and-opportunities-in-oncology/ 2023-12-06T17:39:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-vanda-gastroparesis-treatment/ 2023-12-05T10:45:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/seismic-therapeutic-immunology-pipeline/ 2023-12-05T10:44:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-deal-abbisko-pimicotinib/ 2023-12-05T09:16:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oxford-biomedica-abl-europe/ 2023-12-07T13:09:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cbp-1008-coherent-biopharma-esophageal-squamous-cell-carcinoma-escc-likelihood-of-approval/ 2024-07-05T05:18:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cbp-1008-coherent-biopharma-triple-negative-breast-cancer-tnbc-likelihood-of-approval/ 2024-07-05T05:18:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cbp-1008-coherent-biopharma-endometrial-cancer-likelihood-of-approval/ 2024-07-05T05:18:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cbp-1008-coherent-biopharma-gastric-cancer-likelihood-of-approval/ 2024-07-05T05:18:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cbp-1008-coherent-biopharma-colon-cancer-likelihood-of-approval/ 2024-07-05T05:18:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cbp-1008-coherent-biopharma-cervical-cancer-likelihood-of-approval/ 2024-07-05T05:18:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cbp-1008-coherent-biopharma-lung-cancer-likelihood-of-approval/ 2024-07-05T05:18:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sar-445611-sanofi-inflammation-likelihood-of-approval/ 2023-12-05T06:01:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mc-150-chongqing-precision-biotech-b-cell-acute-lymphocytic-leukemia-b-cell-acute-lymphoblastic-leukaemia-likelihood-of-approval/ 2025-01-20T16:51:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mc-150-chongqing-precision-biotech-b-cell-non-hodgkin-lymphoma-likelihood-of-approval/ 2025-01-20T16:51:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mc-150-chongqing-precision-biotech-follicular-lymphoma-likelihood-of-approval/ 2025-01-20T16:51:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mc-150-chongqing-precision-biotech-mantle-cell-lymphoma-likelihood-of-approval/ 2025-01-20T16:51:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mc-150-chongqing-precision-biotech-diffuse-large-b-cell-lymphoma-likelihood-of-approval/ 2025-01-20T16:51:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mc-150-chongqing-precision-biotech-chronic-lymphocytic-leukemia-cll-likelihood-of-approval/ 2025-01-20T16:51:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eyp-651-enyo-pharma-metabolic-dysfunction-associated-steatohepatitis-mash-likelihood-of-approval/ 2025-01-20T16:51:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ly-3885125-eli-lilly-and-co-metabolic-dysfunction-associated-steatotic-liver-disease-masld-likelihood-of-approval/ 2024-07-05T17:29:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pf-06954522-pfizer-type-2-diabetes-likelihood-of-approval/ 2024-04-20T00:45:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bi-3706674-boehringer-ingelheim-international-adenocarcinoma-of-the-gastroesophageal-junction-likelihood-of-approval/ 2025-01-20T16:51:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bi-3706674-boehringer-ingelheim-international-esophageal-cancer-likelihood-of-approval/ 2025-01-20T16:51:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bi-3706674-boehringer-ingelheim-international-gastric-cancer-likelihood-of-approval/ 2025-01-20T16:51:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tpst-1120-tempest-therapeutics-hepatocellular-carcinoma-likelihood-of-approval/ 2024-07-05T05:17:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pf-07293893-pfizer-congestive-heart-failure-heart-failure-likelihood-of-approval/ 2025-01-20T16:51:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pf-07853578-pfizer-metabolic-dysfunction-associated-steatohepatitis-mash-likelihood-of-approval/ 2025-01-20T16:51:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hyaluronan-fragment-nakhia-impex-cancer-pain-likelihood-of-approval/ 2025-01-20T16:51:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/allostemspine-creative-medical-technology-chronic-low-back-pain-clbp-likelihood-of-approval/ 2024-07-05T17:29:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ck-586-cytokinetics-diastolic-heart-failure-hfpef-likelihood-of-approval/ 2023-12-05T05:48:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/etrumadenant-arcus-biosciences-pancreatic-ductal-adenocarcinoma-likelihood-of-approval/ 2025-01-19T17:48:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pivekimab-sunirine-immunogen-relapsed-acute-myeloid-leukemia-likelihood-of-approval/ 2025-01-19T17:47:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pivekimab-sunirine-immunogen-refractory-acute-myeloid-leukemia-likelihood-of-approval/ 2025-01-19T17:47:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pivekimab-sunirine-immunogen-acute-myelocytic-leukemia-aml-acute-myeloblastic-leukemia-likelihood-of-approval/ 2025-01-19T17:47:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bnt-113-biontech-penile-cancer-likelihood-of-approval/ 2025-01-19T17:47:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tlc-6740-orsobio-metabolic-dysfunction-associated-steatohepatitis-mash-likelihood-of-approval/ 2025-01-20T16:50:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bnt-113-biontech-cervical-cancer-likelihood-of-approval/ 2025-01-19T17:47:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dazukibart-pfizer-systemic-lupus-erythematosus-likelihood-of-approval/ 2025-01-19T17:47:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azd-6234-astrazeneca-obesity-likelihood-of-approval/ 2023-12-05T05:41:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xyf-13-xi-an-yufan-biotechnology-recurrent-glioblastoma-multiforme-gbm-likelihood-of-approval/ 2023-12-05T05:38:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/retifanlimab-incyte-transitional-cell-carcinoma-urothelial-cell-carcinoma-likelihood-of-approval/ 2025-01-19T17:46:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dzd-8586-dizal-pharmaceutical-b-cell-non-hodgkin-lymphoma-likelihood-of-approval/ 2025-01-20T16:50:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mtr-601-motric-bio-muscle-spasticity-likelihood-of-approval/ 2025-01-20T16:50:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cosibelimab-checkpoint-therapeutics-merkel-cell-carcinoma-likelihood-of-approval/ 2024-09-09T01:59:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/imlifidase-hansa-biopharma-guillain-barre-syndrome-likelihood-of-approval/ 2025-01-19T17:45:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cs-0159-cascade-pharmaceuticals-metabolic-dysfunction-associated-steatohepatitis-mash-likelihood-of-approval/ 2025-01-20T16:50:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/s-095029-les-laboratoires-servier-gastric-cancer-likelihood-of-approval/ 2025-01-20T16:50:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arct-2138-seqirus-seasonal-influenza-likelihood-of-approval/ 2024-01-24T19:17:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sabestomig-astrazeneca-adenocarcinoma-of-the-gastroesophageal-junction-likelihood-of-approval/ 2025-01-20T16:50:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sabestomig-astrazeneca-gastric-cancer-likelihood-of-approval/ 2025-01-20T16:50:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cm-101-chemomab-therapeutics-primary-sclerosing-cholangitis-likelihood-of-approval/ 2024-07-05T05:13:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mbk-001-mikrobiomik-healthcare-company-metabolic-dysfunction-associated-steatohepatitis-mash-likelihood-of-approval/ 2025-01-20T16:49:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mrna-1215-moderna-nipah-virus-niv-infections-likelihood-of-approval/ 2023-12-05T05:06:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ad-113-shionogi-apnimed-sleep-science-obstructive-sleep-apnea-likelihood-of-approval/ 2025-01-20T16:49:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lisocabtagene-maraleucel-bristol-myers-squibb-secondary-cns-lymphoma-likelihood-of-approval/ 2025-01-19T17:42:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lisocabtagene-maraleucel-bristol-myers-squibb-chronic-lymphocytic-leukemia-cll-likelihood-of-approval/ 2025-01-19T17:42:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tak-861-takeda-pharmaceutical-type-1-narcolepsy-narcolepsy-with-cataplexy-likelihood-of-approval/ 2025-01-20T16:49:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vonoprazan-acetate-jiangsu-carephar-pharmaceutical-gastric-ulcers-likelihood-of-approval/ 2025-01-20T16:49:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pidnarulex-senhwa-biosciences-prostate-cancer-likelihood-of-approval/ 2024-04-19T01:22:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pegfilgrastim-biosimilar-curateq-biologics-chemotherapy-induced-neutropenia-likelihood-of-approval/ 2025-01-20T16:49:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nt-0796-nodthera-inflammation-likelihood-of-approval/ 2025-01-20T16:49:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/deltacel-kiromic-biopharma-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-07-05T17:26:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bgba-445-beigene-squamous-non-small-cell-lung-cancer-likelihood-of-approval/ 2025-01-20T16:48:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/niraparib-gsk-pancreatic-ductal-adenocarcinoma-likelihood-of-approval/ 2025-01-19T17:20:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/niraparib-gsk-uterine-cancer-likelihood-of-approval/ 2025-01-19T17:20:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nipah-strain-bangladesh-vaccine-public-health-vaccines-nipah-virus-niv-infections-likelihood-of-approval/ 2023-12-05T04:29:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lefelsiran-sodium-novo-nordisk-alcohol-dependence-likelihood-of-approval/ 2023-12-05T04:27:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/blarcamesine-hydrochloride-anavex-life-sciences-infantile-spasm-west-syndrome-likelihood-of-approval/ 2025-01-19T17:18:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/yh-25724-boehringer-ingelheim-international-metabolic-dysfunction-associated-steatotic-liver-disease-masld-likelihood-of-approval/ 2025-01-20T16:48:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xw-004-sciwind-biosciences-obesity-likelihood-of-approval/ 2025-01-19T17:18:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/prgn-2009-precigen-human-papillomavirus-hpv-associated-cancer-likelihood-of-approval/ 2025-01-19T17:18:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ulviprubart-abcuro-inclusion-body-myositis-ibm-likelihood-of-approval/ 2024-05-20T03:47:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tpst-1120-tempest-therapeutics-renal-cell-carcinoma-likelihood-of-approval/ 2024-07-05T01:49:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ar-882-arthrosi-therapeutics-gouty-arthritis-gout-likelihood-of-approval/ 2025-01-20T16:48:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pegozafermin-89bio-metabolic-dysfunction-associated-steatohepatitis-mash-likelihood-of-approval/ 2025-01-20T16:48:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rtp-026-resother-pharma-myocardial-infarction-likelihood-of-approval/ 2025-01-20T16:48:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tg-4050-transgene-head-and-neck-squamous-cell-carcinoma-hnsc-likelihood-of-approval/ 2025-01-20T16:48:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/j-2h1702-j2h-biotech-metabolic-dysfunction-associated-steatohepatitis-mash-likelihood-of-approval/ 2025-01-20T16:48:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/latozinemab-alector-frontotemporal-dementia-ftd-likelihood-of-approval/ 2024-09-09T04:38:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oratrope-lumos-pharma-net-present-value/ 2024-05-16T02:01:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alg-009-aligos-therapeutics-net-present-value/ 2024-06-13T18:49:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cbp-1008-coherent-biopharma-head-and-neck-squamous-cell-carcinoma-hnsc-likelihood-of-approval/ 2024-07-05T17:24:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lefelsiran-sodium-novo-nordisk-net-present-value/ 2024-07-02T02:11:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lunresertib-repare-therapeutics-net-present-value/ 2024-06-13T18:54:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/izokibep-acelyrin-net-present-value/ 2024-06-13T18:54:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mrg-003-shanghai-miracogen-head-and-neck-squamous-cell-carcinoma-hnsc-likelihood-of-approval/ 2025-01-20T16:48:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lonigutamab-ugodotin-acelyrin-net-present-value/ 2024-07-02T02:02:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/qrl-101-quralis-amyotrophic-lateral-sclerosis-likelihood-of-approval/ 2025-01-20T16:48:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tern-601-terns-pharmaceuticals-obesity-likelihood-of-approval/ 2024-04-20T00:35:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bexotegrast-pliant-therapeutics-primary-sclerosing-cholangitis-likelihood-of-approval/ 2025-01-20T16:48:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tn-201-tenaya-therapeutics-net-present-value/ 2024-05-16T02:08:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ft-819-fate-therapeutics-net-present-value/ 2024-05-16T02:08:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tak-227-takeda-pharmaceutical-net-present-value/ 2024-12-13T02:53:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lava-1207-lava-therapeutics-net-present-value/ 2024-07-02T02:10:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ctx-110-crispr-therapeutics-net-present-value/ 2024-06-13T18:49:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/luveltamab-tazevibulin-sutro-biopharma-net-present-value/ 2024-12-13T02:53:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sirexatamab-leap-therapeutics-net-present-value/ 2024-06-13T18:49:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/linavonkibart-scholar-rock-holding-net-present-value/ 2024-05-16T02:07:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/apitegromab-scholar-rock-holding-net-present-value/ 2024-05-16T02:07:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dodekin-philogen-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-06-19T05:37:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dodekin-philogen-melanoma-likelihood-of-approval/ 2024-06-19T05:37:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/venanprubart-eli-lilly-and-co-net-present-value/ 2024-07-02T02:10:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vemircopan-astrazeneca-net-present-value/ 2024-06-13T18:46:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jaktinib-hydrochloride-suzhou-zelgen-biopharmaceutical-post-essential-thrombocythemia-myelofibrosis-post-et-mf-likelihood-of-approval/ 2025-01-20T16:47:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/danuglipron-tromethamine-pfizer-renal-failure-likelihood-of-approval/ 2023-12-05T03:41:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dalzanemdor-sage-therapeutics-net-present-value/ 2024-06-13T18:49:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mb-106-mustang-bio-waldenstrom-macroglobulinemia-lymphoplasmacytic-lymphoma-likelihood-of-approval/ 2025-01-20T16:47:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mrt-2359-monte-rosa-therapeutics-net-present-value/ 2024-06-13T18:48:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sebetralstat-kalvista-pharmaceuticals-hereditary-angioedema-hae-c1-esterase-inhibitor-c1-inh-deficiency-likelihood-of-approval/ 2025-01-20T16:47:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/izalontamab-systimmune-recurrent-head-and-neck-squamous-cell-carcinoma-likelihood-of-approval/ 2025-01-20T16:47:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adi-001-adicet-bio-net-present-value/ 2024-05-16T01:57:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/clesacostat-tromethamine-ervogastat-pfizer-net-present-value/ 2024-04-16T17:01:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gavorestat-applied-therapeutics-net-present-value/ 2024-05-16T01:58:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/remibrutinib-novartis-net-present-value/ 2024-06-13T18:52:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vesigel-urogen-pharma-net-present-value/ 2024-05-16T02:05:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bavdegalutamide-arvinas-net-present-value/ 2024-05-16T01:58:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fg-3246-fibrogen-metastatic-castration-resistant-prostate-cancer-mcrpc-likelihood-of-approval/ 2025-01-20T16:47:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nimodipine-acasti-pharma-net-present-value-3/ 2024-05-16T02:05:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sebetralstat-kalvista-pharmaceuticals-net-present-value/ 2024-06-13T18:48:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cevaretigene-ritoparvovec-meiragtx-net-present-value/ 2024-05-16T02:05:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nn-9500-novo-nordisk-net-present-value/ 2024-12-13T02:51:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mazdutide-innovent-biologics-net-present-value/ 2024-12-13T02:52:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mrna-4157-moderna-squamous-non-small-cell-lung-cancer-likelihood-of-approval/ 2025-01-20T16:47:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dazukibart-pfizer-net-present-value/ 2024-04-16T17:00:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bnt-113-biontech-head-and-neck-squamous-cell-carcinoma-hnsc-likelihood-of-approval/ 2025-01-20T16:47:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mitiperstat-astrazeneca-net-present-value/ 2024-05-16T01:58:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oleclumab-astrazeneca-net-present-value/ 2024-04-16T16:59:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sildenafil-citrate-dare-bioscience-net-present-value/ 2024-05-16T02:03:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pariglasgene-brecaparvovec-ultragenyx-pharmaceutical-net-present-value/ 2024-07-02T02:07:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ef-001-everfront-biotech-glioblastoma-multiforme-gbm-likelihood-of-approval/ 2025-01-20T16:47:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ef-001-everfront-biotech-anaplastic-astrocytoma-likelihood-of-approval/ 2025-01-20T16:46:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/molgradex-savara-net-present-value/ 2024-05-16T02:03:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/avalotcagene-ontaparvovec-ultragenyx-pharmaceutical-net-present-value/ 2024-05-16T02:02:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/escharex-mediwound-net-present-value/ 2024-07-02T02:07:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mazindol-er-nls-pharmaceutics-type-2-narcolepsy-narcolepsy-without-cataplexy-likelihood-of-approval/ 2025-01-20T16:46:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ziltivekimab-novo-nordisk-diastolic-heart-failure-hfpef-likelihood-of-approval/ 2025-01-20T16:46:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aspacytarabine-hydrochloride-ayala-pharmaceuticals-relapsed-acute-myeloid-leukemia-likelihood-of-approval/ 2025-01-20T16:46:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ly-3857210-eli-lilly-and-co-diabetic-neuropathic-pain-likelihood-of-approval/ 2025-01-19T17:01:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aspacytarabine-hydrochloride-ayala-pharmaceuticals-refractory-acute-myeloid-leukemia-likelihood-of-approval/ 2025-01-20T16:46:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aspacytarabine-hydrochloride-ayala-pharmaceuticals-acute-myelocytic-leukemia-aml-acute-myeloblastic-leukemia-likelihood-of-approval/ 2025-01-20T16:46:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/caba-201-cabaletta-bio-net-present-value/ 2024-05-16T02:09:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xw-004-sciwind-biosciences-type-2-diabetes-likelihood-of-approval/ 2025-01-19T17:01:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/decoy-20-indaptus-therapeutics-net-present-value/ 2024-07-02T02:02:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/da-1241-neurobo-pharmaceuticals-metabolic-dysfunction-associated-steatohepatitis-mash-likelihood-of-approval/ 2024-07-05T17:21:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gtx-102-ultragenyx-pharmaceutical-net-present-value/ 2024-06-13T18:49:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ligufalimab-akeso-net-present-value/ 2024-12-13T02:53:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cetuximab-biobetter-shanghai-henlius-biotech-recurrent-head-and-neck-squamous-cell-carcinoma-likelihood-of-approval/ 2025-01-20T16:46:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/endoxifen-atossa-therapeutics-net-present-value-2/ 2024-06-13T18:54:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nalbuphine-hydrochloride-er-trevi-therapeutics-net-present-value/ 2024-06-13T18:54:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cosibelimab-checkpoint-therapeutics-recurrent-head-and-neck-squamous-cell-carcinoma-likelihood-of-approval/ 2024-09-09T04:37:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cosibelimab-checkpoint-therapeutics-oral-cavity-mouth-cancer-likelihood-of-approval/ 2024-09-09T04:37:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cosibelimab-checkpoint-therapeutics-pharyngeal-neoplasm-likelihood-of-approval/ 2024-09-09T04:37:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cosibelimab-checkpoint-therapeutics-laryngeal-cancer-likelihood-of-approval/ 2024-09-09T04:37:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cosibelimab-checkpoint-therapeutics-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-09-09T04:37:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cemiplimab-regeneron-pharmaceuticals-metastatic-uveal-melanoma-likelihood-of-approval/ 2025-01-20T16:46:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gsk-4382276a-gsk-seasonal-influenza-likelihood-of-approval/ 2024-07-05T01:46:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bms-986141-bristol-myers-squibb-coronary-artery-disease-cad-ischemic-heart-disease-likelihood-of-approval/ 2023-12-05T02:51:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mobocertinib-takeda-pharmaceutical-metastatic-biliary-tract-cancer-likelihood-of-approval/ 2025-01-20T16:46:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/com-701-compugen-invasive-ductal-carcinoma-likelihood-of-approval/ 2025-01-20T16:45:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/com-701-compugen-metastatic-breast-cancer-likelihood-of-approval/ 2025-01-20T16:45:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nt-219-purple-biotech-recurrent-head-and-neck-squamous-cell-carcinoma-likelihood-of-approval/ 2025-01-20T16:45:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/remibrutinib-novartis-chronic-urticaria-or-hives-likelihood-of-approval/ 2025-01-19T16:58:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/frexalimab-sanofi-type-1-diabetes-juvenile-diabetes-likelihood-of-approval/ 2025-01-20T16:45:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cetuximab-sarotalocan-rakuten-medical-cutaneous-squamous-cell-carcinoma-cscc-likelihood-of-approval/ 2025-01-20T16:45:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tegoprubart-eledon-pharmaceuticals-kidney-transplant-rejection-likelihood-of-approval/ 2025-01-19T16:58:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cetuximab-sarotalocan-rakuten-medical-recurrent-head-and-neck-squamous-cell-carcinoma-likelihood-of-approval/ 2025-01-20T16:45:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alks-2680-synchronicity-pharma-type-2-narcolepsy-narcolepsy-without-cataplexy-likelihood-of-approval/ 2025-01-20T16:45:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alks-2680-synchronicity-pharma-type-1-narcolepsy-narcolepsy-with-cataplexy-likelihood-of-approval/ 2025-01-20T16:45:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alks-2680-synchronicity-pharma-idiopathic-hypersomnia-ih-likelihood-of-approval/ 2025-01-20T16:45:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gorlin-syndrome-basal-cell-nevus-syndrome-nevoid-basal-cell-carcinoma-syndrome-drugs-in-development/ 2024-09-27T03:30:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/encephalomyelitis-drugs-in-development/ 2024-09-27T03:26:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/prader-willi-syndrome-pws-drugs-in-development/ 2024-09-27T03:54:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/synovial-sarcoma-drugs-in-development/ 2024-09-27T04:03:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hospital-acquired-pneumonia-hap-drugs-in-development/ 2024-09-27T03:34:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/optic-neuropathy-drugs-in-development/ 2024-09-27T03:49:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ventilator-associated-pneumonia-vap-drugs-in-development/ 2024-09-27T04:07:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/community-acquired-pneumonia-drugs-in-development/ 2024-09-27T03:22:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/b-cell-chronic-lymphocytic-leukemia-drugs-in-development/ 2024-09-27T03:17:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/itacitinib-adipate-incyte-bronchiolitis-obliterans-likelihood-of-approval/ 2023-12-05T02:27:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/becker-muscular-dystrophy-drugs-in-development/ 2024-09-27T03:17:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cognitive-impairment-associated-with-schizophrenia-cias-drugs-in-development/ 2024-09-27T03:21:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/diabetic-peripheral-neuropathy-drugs-in-development/ 2024-09-27T03:24:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/leiomyosarcoma-drugs-in-development/ 2024-09-27T03:38:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/degenerative-disc-disease-drugs-in-development/ 2024-09-27T03:23:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/influenza-a-virus-h3n2-subtype-infections-drugs-in-development/ 2024-09-27T03:36:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/male-hypogonadism-drugs-in-development/ 2024-09-27T03:40:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ischemia-reperfusion-injury-drugs-in-development/ 2024-09-27T03:37:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/periodontitis-drugs-in-development/ 2024-09-27T03:51:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/uterine-leiomyoma-uterine-fibroids-drugs-in-development/ 2024-09-27T04:06:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/house-dust-mite-allergy-drugs-in-development/ 2024-09-27T03:34:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mumps-drugs-in-development/ 2024-09-27T03:44:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/functional-non-ulcer-dyspepsia-drugs-in-development/ 2024-09-27T03:29:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/osteogenesis-imperfecta-drugs-in-development/ 2024-09-27T03:49:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/medi-0457-astrazeneca-head-and-neck-squamous-cell-carcinoma-hnsc-likelihood-of-approval/ 2025-01-20T16:44:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/juvenile-macular-degeneration-stargardt-disease-drugs-in-development/ 2024-09-27T03:37:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/botulism-drugs-in-development/ 2024-09-27T03:18:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/secondary-hyperparathyroidism-drugs-in-development/ 2024-09-27T04:00:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/proliferative-vitreoretinopathy-pvr-drugs-in-development/ 2024-09-27T03:56:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sandhoff-disease-jatzkewitz-pilz-syndrome-drugs-in-development/ 2024-09-27T04:00:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/idiopathic-thrombocytopenic-purpura-immune-thrombocytopenic-purpura-drugs-in-development/ 2024-09-27T03:36:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/albumin-human-grifols-decompensated-cirrhosis-likelihood-of-approval/ 2024-07-05T17:18:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/spinal-muscular-atrophy-sma-drugs-in-development/ 2024-09-27T04:02:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/phenylketonuria-pku-drugs-in-development/ 2024-09-27T03:52:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dostarlimab-gsk-recurrent-head-and-neck-squamous-cell-carcinoma-likelihood-of-approval/ 2025-01-20T16:44:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/venous-leg-ulcers-crural-ulcer-drugs-in-development/ 2024-09-27T04:07:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/trigeminal-neuralgia-tic-douloureux-drugs-in-development/ 2024-09-27T04:05:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chemotherapy-induced-nausea-and-vomiting-drugs-in-development/ 2024-09-27T03:19:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chemotherapy-induced-neutropenia-drugs-in-development/ 2024-09-27T03:20:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cat-allergy-drugs-in-development/ 2023-12-05T02:19:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/grass-pollen-allergy-drugs-in-development/ 2024-09-27T03:31:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nasopharyngitis-common-cold-drugs-in-development/ 2024-09-27T03:45:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/birch-pollen-allergy-drugs-in-development/ 2024-09-27T03:17:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/candidiasis-drugs-in-development/ 2024-09-27T03:18:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/african-trypanosomiasis-drugs-in-development/ 2024-09-27T03:13:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/enfortumab-vedotin-astellas-pharma-head-and-neck-squamous-cell-carcinoma-hnsc-likelihood-of-approval/ 2025-01-20T16:44:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/osteomyelitis-drugs-in-development/ 2024-09-27T03:49:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/plague-drugs-in-development/ 2024-09-27T03:52:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tmp-301-tempero-bio-alcohol-dependence-likelihood-of-approval/ 2025-01-20T16:44:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/colitis-drugs-in-development/ 2024-09-27T03:21:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/granulomatosis-with-polyangiitis-wegener-s-granulomatosis-drugs-in-development/ 2024-09-27T03:31:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/myocarditis-drugs-in-development/ 2024-09-27T03:45:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nasal-polyps-nasal-polyposis-drugs-in-development/ 2024-09-27T03:45:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/blepharitis-drugs-in-development/ 2024-09-27T03:18:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dilated-cardiomyopathy-drugs-in-development/ 2024-09-27T03:24:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cholera-drugs-in-development/ 2024-09-27T03:20:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cryptococcosis-drugs-in-development/ 2024-09-27T03:23:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bacterial-vaginosis-drugs-in-development/ 2024-09-27T03:17:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bronchopulmonary-dysplasia-drugs-in-development/ 2024-09-27T03:18:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nasopharyngeal-cancer-drugs-in-development/ 2024-09-27T03:45:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/left-ventricular-dysfunction-drugs-in-development/ 2024-09-27T03:38:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alpha-1-antitrypsin-deficiency-a1ad-drugs-in-development/ 2024-09-27T03:14:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/severe-acute-respiratory-syndrome-sars-drugs-in-development/ 2024-09-27T04:01:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/primary-sclerosing-cholangitis-drugs-in-development/ 2024-09-27T03:55:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acute-respiratory-distress-syndrome-drugs-in-development/ 2024-09-27T03:12:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cluster-headache-syndrome-cluster-headache-drugs-in-development/ 2024-09-27T03:21:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hyperalgesia-drugs-in-development/ 2024-09-27T03:34:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/down-syndrome-drugs-in-development/ 2024-09-27T03:25:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/batten-disease-drugs-in-development/ 2024-09-27T03:17:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ca-102n-holy-stone-healthcare-metastatic-colorectal-cancer-likelihood-of-approval/ 2025-01-19T16:55:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bone-marrow-transplant-rejection-drugs-in-development/ 2024-09-27T03:18:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/myocardial-ischemia-drugs-in-development/ 2024-09-27T03:45:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/diazoxide-choline-cr-soleno-therapeutics-prader-willi-syndrome-pws-likelihood-of-approval/ 2025-01-20T16:44:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ocular-hypertension-drugs-in-development/ 2024-09-27T03:48:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/thromboembolism-drugs-in-development/ 2024-09-27T04:04:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/intermittent-claudication-drugs-in-development/ 2024-09-27T03:37:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/viral-conjunctivitis-drugs-in-development/ 2024-09-27T04:07:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/insulin-resistance-drugs-in-development/ 2024-09-27T03:37:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fabry-disease-drugs-in-development/ 2024-09-27T03:27:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/liver-cirrhosis-drugs-in-development/ 2024-09-27T03:39:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/myasthenia-gravis-drugs-in-development/ 2024-09-27T03:44:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alopecia-drugs-in-development/ 2024-09-27T03:14:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pruritus-drugs-in-development/ 2024-09-27T03:56:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/obsessive-compulsive-disorder-drugs-in-development/ 2024-09-27T03:48:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/attention-deficit-hyperactivity-disorder-adhd-drugs-in-development/ 2024-09-27T03:16:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cerebral-palsy-drugs-in-development/ 2024-09-27T03:19:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amyloidosis-drugs-in-development/ 2024-09-27T03:14:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hypoglycemia-drugs-in-development/ 2024-09-27T03:35:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cbp-1008-coherent-biopharma-pancreatic-cancer-likelihood-of-approval/ 2024-07-05T01:42:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hepatic-encephalopathy-drugs-in-development/ 2024-09-27T03:32:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/primary-biliary-cholangitis-primary-biliary-cirrhosis-drugs-in-development/ 2024-09-27T03:55:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hidradenitis-suppurativa-drugs-in-development/ 2024-09-27T03:33:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/reflux-esophagitis-gastroesophageal-reflux-disease-drugs-in-development/ 2024-09-27T03:58:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anal-cancer-drugs-in-development/ 2024-09-27T03:14:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rectal-cancer-drugs-in-development/ 2024-09-27T03:57:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acimtamig-affimed-transformed-mycosis-fungoides-likelihood-of-approval/ 2025-01-21T16:57:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/genital-herpes-drugs-in-development/ 2024-09-27T03:30:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/smallpox-drugs-in-development/ 2024-09-27T04:01:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acimtamig-affimed-cutaneous-t-cell-lymphoma-likelihood-of-approval/ 2025-01-20T16:43:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acimtamig-affimed-angioimmunoblastic-t-cell-lymphoma-aitl-immunoblastic-lymphadenopathy-likelihood-of-approval/ 2025-01-20T16:43:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/diarrhea-drugs-in-development/ 2024-09-27T03:24:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/familial-adenomatous-polyposis-drugs-in-development/ 2024-09-27T03:27:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acimtamig-affimed-hodgkin-lymphoma-b-cell-hodgkin-lymphoma-likelihood-of-approval/ 2025-01-20T16:43:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sarcopenia-drugs-in-development/ 2024-09-27T04:00:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lyme-disease-drugs-in-development/ 2024-09-27T03:40:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/typhoid-fever-drugs-in-development/ 2024-09-27T04:06:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/diabetic-nephropathy-drugs-in-development/ 2024-09-27T03:24:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tourette-syndrome-drugs-in-development/ 2024-09-27T04:05:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/polycythemia-vera-drugs-in-development/ 2024-09-27T03:53:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/duchenne-muscular-dystrophy-drugs-in-development/ 2024-09-27T03:25:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chronic-inflammatory-demyelinating-polyneuropathy-cidp-drugs-in-development/ 2024-09-27T03:21:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/primary-immune-deficiency-pid-drugs-in-development/ 2024-09-27T03:55:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oral-mucositis-drugs-in-development/ 2024-09-27T03:49:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/otitis-media-drugs-in-development/ 2024-09-27T03:50:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/systemic-sclerosis-scleroderma-drugs-in-development/ 2024-09-27T04:03:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mifepristone-corcept-therapeutics-alcohol-dependence-likelihood-of-approval/ 2025-01-20T16:43:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/thalassemia-drugs-in-development/ 2024-09-27T04:04:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fibromyalgia-fibromyalgia-syndrome-drugs-in-development/ 2024-09-27T03:28:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pulmonary-embolism-drugs-in-development/ 2024-09-27T03:56:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iron-deficiency-anemia-drugs-in-development/ 2024-09-27T03:37:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hodgkin-lymphoma-b-cell-hodgkin-lymphoma-drugs-in-development/ 2024-09-27T03:33:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/diabetic-macular-edema-drugs-in-development/ 2024-09-27T03:24:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/remibrutinib-novartis-hidradenitis-suppurativa-likelihood-of-approval/ 2025-01-19T16:53:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/remibrutinib-novartis-relapsing-remitting-multiple-sclerosis-rrms-likelihood-of-approval/ 2025-01-19T16:53:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/erectile-dysfunction-drugs-in-development/ 2024-09-27T03:26:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/diabetic-gastroparesis-drugs-in-development/ 2024-09-27T03:24:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anthrax-drugs-in-development/ 2024-09-27T03:15:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/onychomycosis-tinea-unguium-drugs-in-development/ 2024-09-27T03:49:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/belinostat-acrotech-biopharma-natural-killer-cell-lymphomas-likelihood-of-approval/ 2025-01-20T16:43:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/traumatic-brain-injury-drugs-in-development/ 2024-09-27T04:05:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acute-renal-failure-arf-acute-kidney-injury-drugs-in-development/ 2024-09-27T03:12:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bi-836880-boehringer-ingelheim-international-wet-neovascular-exudative-macular-degeneration-likelihood-of-approval/ 2024-07-05T17:17:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/censavudine-transposon-therapeutics-progressive-supranuclear-palsy-likelihood-of-approval/ 2025-01-20T16:43:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/restless-legs-syndrome-drugs-in-development/ 2024-09-27T03:58:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/post-traumatic-stress-disorder-ptsd-drugs-in-development/ 2024-09-27T03:54:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dyslipidemia-drugs-in-development/ 2024-09-27T03:25:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/urinary-incontinence-drugs-in-development/ 2024-09-27T04:06:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arrhythmias-drugs-in-development/ 2024-09-27T03:16:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/atrial-fibrillation-drugs-in-development/ 2024-09-27T03:16:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/middle-east-respiratory-syndrome-mers-drugs-in-development/ 2024-09-27T03:43:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gonorrhea-drugs-in-development/ 2024-09-27T03:30:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/olutasidenib-rigel-pharmaceuticals-acute-myelocytic-leukemia-aml-acute-myeloblastic-leukemia-likelihood-of-approval/ 2025-01-19T16:52:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fibrodysplasia-ossificans-progressiva-myositis-ossificans-progressiva-drugs-in-development/ 2024-09-27T03:28:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/merkel-cell-carcinoma-drugs-in-development/ 2024-09-27T03:42:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ornithine-transcarbamylase-deficiency-drugs-in-development/ 2024-09-27T03:49:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/multiple-system-atrophy-msa-or-shy-drager-syndrome-or-multi-system-degeneration-drugs-in-development/ 2024-09-27T03:44:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zika-virus-infections-drugs-in-development/ 2024-09-27T04:08:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/influenza-a-virus-h7n9-subtype-infections-drugs-in-development/ 2024-09-27T03:36:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inclusion-body-myositis-ibm-drugs-in-development/ 2024-09-27T03:36:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/leber-congenital-amaurosis-lca-drugs-in-development/ 2024-09-27T03:38:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pontine-glioma-drugs-in-development/ 2024-09-27T03:53:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anaplastic-oligoastrocytoma-drugs-in-development/ 2024-09-27T03:14:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lassa-fever-lassa-hemorrhagic-fever-drugs-in-development/ 2024-09-27T03:38:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/metachromatic-leukodystrophy-mld-drugs-in-development/ 2024-09-27T03:42:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/uveal-melanoma-drugs-in-development/ 2024-09-27T04:06:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/heterozygous-familial-hypercholesterolemia-hefh-drugs-in-development/ 2024-09-27T03:33:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nephrotic-syndrome-drugs-in-development/ 2024-09-27T03:46:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/epstein-barr-virus-hhv-4-infections-drugs-in-development/ 2024-09-27T03:26:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abgn-268-altrubio-ulcerative-colitis-likelihood-of-approval/ 2025-01-19T16:51:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sickle-cell-disease-with-vaso-occlusive-crisis-drugs-in-development/ 2024-09-27T04:01:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/achondroplasia-drugs-in-development/ 2024-09-27T03:11:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dermatomyositis-drugs-in-development/ 2024-09-27T03:24:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/myocardial-fibrosis-drugs-in-development/ 2024-09-27T03:45:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/olutasidenib-rigel-pharmaceuticals-myelodysplastic-syndrome-likelihood-of-approval/ 2025-01-19T16:51:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vancomycin-resistant-staphylococcus-aureus-vrsa-infections-drugs-in-development/ 2024-09-27T04:06:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/marburgvirus-infections-marburg-hemorrhagic-fever-drugs-in-development/ 2024-09-27T03:41:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ebolavirus-infections-ebola-hemorrhagic-fever-drugs-in-development/ 2024-09-27T03:25:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/resistant-pseudomonas-aeruginosa-infections-drugs-in-development/ 2024-09-27T03:58:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/post-polycythemia-vera-myelofibrosis-ppv-mf-drugs-in-development/ 2024-09-27T03:54:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neuromyelitis-optica-devic-s-syndrome-drugs-in-development/ 2024-09-27T03:47:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/niraparib-gsk-recurrent-glioblastoma-multiforme-gbm-likelihood-of-approval/ 2025-01-19T16:45:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ureter-cancer-drugs-in-development/ 2024-09-27T04:06:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/female-hypoactive-sexual-desire-disorder-drugs-in-development/ 2024-09-27T03:28:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/familial-amyloid-neuropathies-drugs-in-development/ 2024-09-27T03:27:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/human-papillomavirus-hpv-associated-cancer-drugs-in-development/ 2024-09-27T03:34:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hand-foot-and-mouth-disease-drugs-in-development/ 2024-09-27T03:31:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/male-infertility-drugs-in-development/ 2024-09-27T03:40:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alcoholic-hepatitis-drugs-in-development/ 2024-09-27T03:13:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/paroxysmal-nocturnal-hemoglobinuria-drugs-in-development/ 2024-09-27T03:51:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/radiodermatitis-drugs-in-development/ 2024-09-27T03:57:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/progressive-supranuclear-palsy-drugs-in-development/ 2024-09-27T03:56:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/resmetirom-madrigal-pharmaceuticals-metabolic-dysfunction-associated-steatotic-liver-disease-masld-likelihood-of-approval/ 2024-06-19T05:34:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neuroendocrine-tumors-drugs-in-development/ 2024-09-27T03:46:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arterial-thrombosis-drugs-in-development/ 2024-09-27T03:16:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pds-0101-pds-biotechnology-recurrent-head-and-neck-squamous-cell-carcinoma-likelihood-of-approval/ 2024-05-20T03:41:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/peripheral-nerve-sheath-tumor-neurofibrosarcoma-drugs-in-development/ 2024-09-27T03:52:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neurofibromatoses-type-i-von-recklinghausen-s-disease-drugs-in-development/ 2024-09-27T03:46:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/psoriatic-arthritis-drugs-in-development/ 2024-09-27T03:56:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/recurrent-malignant-glioma-drugs-in-development/ 2024-09-27T03:57:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rotavirus-infections-drugs-in-development/ 2024-09-27T03:59:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rubella-german-measles-drugs-in-development/ 2024-09-27T03:59:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/end-stage-kidney-disease-end-stage-renal-disease-or-esrd-drugs-in-development/ 2024-09-27T03:26:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chikungunya-fever-drugs-in-development/ 2024-09-27T03:20:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/influenza-a-virus-h5n1-subtype-infections-drugs-in-development/ 2024-09-27T03:36:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/encephalopathy-drugs-in-development/ 2024-09-27T03:26:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/proliferative-diabetic-retinopathy-pdr-drugs-in-development/ 2024-09-27T03:56:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/leber-s-hereditary-optic-neuropathy-leber-optic-atrophy-drugs-in-development/ 2024-09-27T03:38:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cetuximab-eli-lilly-and-co-cutaneous-squamous-cell-carcinoma-cscc-likelihood-of-approval/ 2025-01-20T16:43:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/keloids-drugs-in-development/ 2024-09-27T03:37:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/axillary-hyperhidrosis-drugs-in-development/ 2024-09-27T03:16:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chemotherapy-induced-peripheral-neuropathy-drugs-in-development/ 2024-09-27T03:20:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ankylosing-spondylitis-bekhterev-s-disease-drugs-in-development/ 2024-09-27T03:15:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mucopolysaccharidosis-iii-mps-iii-sanfilippo-syndrome-drugs-in-development/ 2024-09-27T03:43:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/western-equine-encephalitis-drugs-in-development/ 2024-09-27T04:08:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mucopolysaccharidosis-i-mps-i-hurler-syndrome-drugs-in-development/ 2024-09-27T03:43:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mucopolysaccharidosis-ii-mps-ii-hunter-syndrome-drugs-in-development/ 2024-09-27T03:43:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aplastic-anemia-drugs-in-development/ 2024-09-27T03:15:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/osteonecrosis-drugs-in-development/ 2024-09-27T03:50:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/muscular-dystrophy-drugs-in-development/ 2024-09-27T03:44:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/premature-labor-tocolysis-drugs-in-development/ 2024-09-27T03:55:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rocatinlimab-kyowa-kirin-atopic-dermatitis-atopic-eczema-likelihood-of-approval/ 2025-01-19T16:43:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pyelonephritis-drugs-in-development/ 2024-09-27T03:57:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kaposi-sarcoma-drugs-in-development/ 2024-09-27T03:37:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ventricular-tachycardia-drugs-in-development/ 2024-09-27T04:07:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/methicillin-susceptible-staphylococcus-aureus-mssa-infections-drugs-in-development/ 2024-09-27T03:43:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hyperinsulinemia-drugs-in-development/ 2024-09-27T03:34:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hairy-cell-leukemia-drugs-in-development/ 2024-09-27T03:31:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cryptosporidiosis-drugs-in-development/ 2024-09-27T03:23:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/progressive-multifocal-leukoencephalopathy-drugs-in-development/ 2024-09-27T03:56:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/escherichia-coli-infections-drugs-in-development/ 2024-09-27T03:27:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/impetigo-drugs-in-development/ 2024-09-27T03:36:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/graves-ophthalmopathy-drugs-in-development/ 2024-09-27T03:31:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/graves-diseases-drugs-in-development/ 2024-09-27T03:31:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/spinocerebellar-ataxia-sca-drugs-in-development/ 2024-09-27T04:02:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hypereosinophilic-syndrome-drugs-in-development/ 2024-09-27T03:34:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tinnitus-drugs-in-development/ 2024-09-27T04:05:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fanconi-anemia-drugs-in-development/ 2024-09-27T03:28:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hypertrophic-cardiomyopathy-drugs-in-development/ 2024-09-27T03:35:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/spinal-cord-injury-drugs-in-development/ 2024-09-27T04:02:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/optic-neuritis-drugs-in-development/ 2024-09-27T03:49:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/presbyopia-drugs-in-development/ 2024-09-27T03:55:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gouty-arthritis-gout-drugs-in-development/ 2024-09-27T03:31:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/malignant-pleural-effusion-drugs-in-development/ 2024-09-27T03:40:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aspergillosis-drugs-in-development/ 2024-09-27T03:16:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/influenzavirus-b-infections-drugs-in-development/ 2024-09-27T03:36:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anaphylaxis-drugs-in-development/ 2024-09-27T03:14:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tinea-pedis-athlete-foot-drugs-in-development/ 2024-09-27T04:05:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pompe-disease-drugs-in-development/ 2024-09-27T03:53:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hypoparathyroidism-drugs-in-development/ 2024-09-27T03:35:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/contact-dermatitis-drugs-in-development/ 2024-09-27T03:22:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/systemic-mastocytosis-drugs-in-development/ 2024-09-27T04:03:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lung-transplant-rejection-drugs-in-development/ 2024-09-27T03:39:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/retinitis-pigmentosa-retinitis-drugs-in-development/ 2024-09-27T03:58:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oropharyngeal-cancer-drugs-in-development/ 2024-09-27T03:49:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/behcet-disease-drugs-in-development/ 2024-09-27T03:17:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bronchiectasis-drugs-in-development/ 2024-09-27T03:18:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hypopharyngeal-cancer-drugs-in-development/ 2024-09-27T03:35:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/peritonitis-drugs-in-development/ 2024-09-27T03:52:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pancreatitis-drugs-in-development/ 2024-09-27T03:50:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/atherosclerosis-drugs-in-development/ 2024-09-27T03:16:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gastritis-drugs-in-development/ 2024-09-27T03:29:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/secondary-hypogonadotropic-hypogonadism-drugs-in-development/ 2024-09-27T04:00:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/germany-remains-europes-top-fdi-destination/ 2023-12-04T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharma-industry-groups-push-initiatives-against-climate-change-at-cop28/ 2023-12-05T11:34:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/everest-inches-towards-clinical-studies-for-renal-disease-drug-in-china/ 2023-12-04T17:18:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gallium-maltolate-titan-pharmaceuticals-glioblastoma-multiforme-gbm-likelihood-of-approval/ 2023-12-04T17:12:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pitolisant-hydrochloride-harmony-biosciences-prader-willi-syndrome-pws-likelihood-of-approval/ 2025-01-19T16:41:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/niraparib-gsk-cervical-cancer-likelihood-of-approval/ 2025-01-19T16:39:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/niraparib-gsk-gastric-cancer-likelihood-of-approval/ 2025-01-19T16:39:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/niraparib-johnson-johnson-prostate-cancer-likelihood-of-approval/ 2025-01-19T16:39:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ipilimumab-bristol-myers-squibb-metastatic-adenocarcinoma-of-the-pancreas-likelihood-of-approval/ 2025-01-19T16:39:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/niraparib-gsk-renal-cell-carcinoma-likelihood-of-approval/ 2025-01-19T16:39:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/absci-and-astrazeneca-sign-deal-on-ai-powered-cancer-antibody-drug/ 2023-12-04T15:01:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cancer-research-uk-partners-with-guardant-to-advance-cancer-development/ 2023-12-04T17:09:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/palvella-and-ligand-partner-for-phase-iii-rare-lymphatic-tumour-trial/ 2023-12-05T11:41:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/game-changing-how-ai-and-automation-is-revolutionising-clinical-trial-admin/ 2023-12-04T15:16:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gc-biopharma-mrna-manufacturing-plant/ 2023-12-07T13:09:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-to-acquire-carmot-therapeutics/ 2023-12-04T10:55:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-ambio-osteoporosis/ 2023-12-04T09:10:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-approval-jaypirca-cll-sll-iadults/ 2023-12-04T09:11:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-sues-more-florida-pharmacies-in-battle-against-fake-semaglutide/ 2023-12-01T17:11:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/consumer-healthcare-innovation/ 2024-03-13T17:14:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/partnership-deals-for-psychedelic-drugs-take-a-trip-with-500-surge-in-2023/ 2023-12-01T17:03:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/phenomic-scores-two-deals-in-two-days-with-boehringer-and-astellas/ 2023-12-01T15:28:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-clears-ind-for-biora-therapeuticss-ulcerative-colitis-drug/ 2023-12-01T15:27:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/orchard-secures-fda-fast-track-designation-for-hurler-syndrome-gene-therapy/ 2023-12-07T13:09:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-keytruda-padcev-urothelial-cancer/ 2023-12-01T10:38:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-sanofi-anti-tl1a-therapy/ 2023-12-01T10:39:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biocon-biosimilars-business-viatris-europe/ 2023-12-01T09:29:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-durvalumab-bile-duct-cancers/ 2023-12-01T09:32:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-future-of-cell-and-gene-therapy-manufacturing/ 2023-11-30T23:03:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/herpes-labialis-oral-herpes-drugs-in-development/ 2024-09-27T03:33:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/heart-transplant-rejection-drugs-in-development/ 2024-09-27T03:31:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/peptic-ulcers-drugs-in-development/ 2024-09-27T03:51:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/liver-transplant-rejection-drugs-in-development/ 2024-09-27T03:39:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/uveitis-drugs-in-development/ 2024-09-27T04:06:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/respiratory-syncytial-virus-rsv-infections-drugs-in-development/ 2024-09-27T03:58:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bacterial-conjunctivitis-drugs-in-development/ 2024-09-27T03:17:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cataract-drugs-in-development/ 2024-09-27T03:19:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gliosarcoma-drugs-in-development/ 2024-09-27T03:30:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rhabdomyosarcoma-drugs-in-development/ 2024-09-27T03:59:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tetanus-drugs-in-development/ 2024-09-27T04:04:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/influenza-a-virus-h1n1-subtype-infections-drugs-in-development/ 2024-09-27T03:36:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wilson-disease-drugs-in-development/ 2024-09-27T04:08:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pertussis-whooping-cough-drugs-in-development/ 2024-09-27T03:52:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glomerulonephritis-drugs-in-development/ 2024-09-27T03:30:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/celiac-disease-drugs-in-development/ 2024-09-27T03:19:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/liver-failure-hepatic-insufficiency-drugs-in-development/ 2024-09-27T03:39:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gastric-ulcers-drugs-in-development/ 2024-09-27T03:29:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mild-cognitive-impairment-drugs-in-development/ 2024-09-27T03:43:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/opium-opioid-addiction-drugs-in-development/ 2024-09-27T03:49:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/polycystic-ovarian-syndrome-drugs-in-development/ 2024-09-27T03:53:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hypercholesterolemia-drugs-in-development/ 2024-09-27T03:34:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/macular-edema-drugs-in-development/ 2024-09-27T03:40:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/retinoblastoma-drugs-in-development/ 2024-09-27T03:59:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cancer-anorexia-cachexia-syndrome-drugs-in-development/ 2024-09-27T03:18:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cervical-intraepithelial-neoplasia-cin-drugs-in-development/ 2024-09-27T03:19:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sicca-syndrome-sjogren-drugs-in-development/ 2024-09-27T04:01:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/meningitis-drugs-in-development/ 2024-09-27T03:41:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bullous-pemphigoid-drugs-in-development/ 2024-09-27T03:18:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pemphigus-vulgaris-drugs-in-development/ 2024-09-27T03:51:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neuroblastoma-drugs-in-development/ 2024-09-27T03:46:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/short-bowel-syndrome-drugs-in-development/ 2024-09-27T04:01:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vaginal-cancer-drugs-in-development/ 2024-09-27T04:06:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/usher-syndrome-drugs-in-development/ 2024-09-27T04:06:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adrenocortical-carcinoma-adrenal-cortex-cancer-drugs-in-development/ 2024-09-27T03:13:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/thyroid-cancer-drugs-in-development/ 2024-09-27T04:04:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gallbladder-cancer-drugs-in-development/ 2024-09-27T03:29:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/basal-cell-carcinoma-basal-cell-epithelioma-drugs-in-development/ 2024-09-27T03:17:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/medulloblastoma-drugs-in-development/ 2024-09-27T03:41:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oligodendroglioma-drugs-in-development/ 2024-09-27T03:49:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chondrosarcoma-drugs-in-development/ 2024-09-27T03:20:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anaplastic-astrocytoma-drugs-in-development/ 2024-09-27T03:14:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/malaria-drugs-in-development/ 2024-09-27T03:40:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ewing-sarcoma-drugs-in-development/ 2024-09-27T03:27:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hyperuricemia-drugs-in-development/ 2024-09-27T03:35:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/axial-spondyloarthritis-drugs-in-development/ 2024-09-27T03:16:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/insomnia-drugs-in-development/ 2024-09-27T03:37:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fragile-x-syndrome-drugs-in-development/ 2024-09-27T03:28:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hepatitis-a-drugs-in-development/ 2024-09-27T03:32:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/poliomyelitis-drugs-in-development/ 2024-09-27T03:53:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/leishmaniasis-kala-azar-drugs-in-development/ 2024-09-27T03:38:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cytomegalovirus-hhv-5-infections-drugs-in-development/ 2024-09-27T03:23:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/organophosphate-and-carbamate-poisoning-drugs-in-development/ 2024-09-27T03:49:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/deep-vein-thrombosis-dvt-drugs-in-development/ 2024-09-27T03:23:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rabies-drugs-in-development/ 2024-09-27T03:57:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/heavy-metal-poisoning-drugs-in-development/ 2024-09-27T03:31:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/herpes-zoster-shingles-drugs-in-development/ 2024-09-27T03:33:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tuberculosis-drugs-in-development/ 2024-09-27T04:05:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anemia-in-chronic-kidney-disease-renal-anemia-drugs-in-development/ 2024-09-27T03:15:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/essential-thrombocythemia-drugs-in-development/ 2024-09-27T03:27:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/methicillin-resistant-staphylococcus-aureus-mrsa-infections-drugs-in-development/ 2024-09-27T03:43:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dyskinesia-drugs-in-development/ 2024-09-27T03:25:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/keratoconjunctivitis-sicca-dry-eye-drugs-in-development/ 2024-09-27T03:38:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/post-menopausal-osteoporosis-drugs-in-development/ 2024-09-27T03:54:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gastrointestinal-stromal-tumor-gist-drugs-in-development/ 2024-09-27T03:29:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/diabetic-retinopathy-drugs-in-development/ 2024-09-27T03:24:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kidney-transplant-rejection-drugs-in-development/ 2024-09-27T03:38:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dengue-fever-drugs-in-development/ 2024-09-27T03:24:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hereditary-angioedema-hae-c1-esterase-inhibitor-c1-inh-deficiency-drugs-in-development/ 2024-09-27T03:33:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/graft-versus-host-disease-gvhd-drugs-in-development/ 2024-09-27T03:31:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chemotherapy-induced-anemia-drugs-in-development/ 2024-09-27T03:19:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/thrombotic-thrombocytopenic-purpura-moschcowitz-disease-drugs-in-development/ 2024-09-27T04:04:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/diabetic-neuropathy-drugs-in-development/ 2024-09-27T03:24:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sinusitis-drugs-in-development/ 2024-09-27T04:01:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/globoid-cell-leukodystrophy-krabbe-disease-drugs-in-development/ 2024-09-27T03:30:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/huntington-disease-drugs-in-development/ 2024-09-27T03:34:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/critical-limb-ischemia-drugs-in-development/ 2024-09-27T03:22:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/friedreich-ataxia-drugs-in-development/ 2024-09-27T03:28:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hyperphosphatemia-in-chronic-kidney-disease-drugs-in-development/ 2024-09-27T03:34:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/actinic-solar-keratosis-drugs-in-development/ 2024-09-27T03:12:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acromegaly-drugs-in-development/ 2024-09-27T03:12:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hypothyroidism-drugs-in-development/ 2024-09-27T03:35:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hemophilia-b-factor-ix-deficiency-drugs-in-development/ 2024-09-27T03:32:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pheochromocytoma-drugs-in-development/ 2024-09-27T03:52:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/retinal-vein-occlusion-drugs-in-development/ 2024-09-27T03:58:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/female-sexual-dysfunction-drugs-in-development/ 2024-09-27T03:28:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chronic-myelocytic-leukemia-cml-chronic-myeloid-leukemia-drugs-in-development/ 2024-09-27T03:21:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/allergic-conjunctivitis-drugs-in-development/ 2024-09-27T03:13:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/diabetic-foot-ulcers-drugs-in-development/ 2024-09-27T03:24:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gaucher-disease-drugs-in-development/ 2024-09-27T03:29:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/benign-prostatic-hyperplasia-drugs-in-development/ 2024-09-27T03:17:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hepatitis-c-drugs-in-development/ 2024-09-27T03:33:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/peripheral-arterial-disease-pad-peripheral-vascular-disease-pvd-drugs-in-development/ 2024-09-27T03:51:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/irritable-bowel-syndrome-drugs-in-development/ 2024-09-27T03:37:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/osteoporosis-drugs-in-development/ 2024-09-27T03:50:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pulmonary-arterial-hypertension-drugs-in-development/ 2024-09-27T03:56:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/schizophrenia-drugs-in-development/ 2024-09-27T04:00:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/female-contraception-drugs-in-development/ 2024-09-27T03:28:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/myocardial-infarction-drugs-in-development/ 2024-09-27T03:45:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glaucoma-drugs-in-development/ 2024-09-27T03:30:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-diversifies-oncology-portfolio-with-10-1-bn-immunogen-acquisition/ 2023-11-30T18:17:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pepper-wins-6-5m-to-develop-transomics-drug-discovery-platform/ 2023-12-06T15:16:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/where-do-anti-tumor-necrosis-factor-like-cytokine-agents-go-now/ 2023-11-30T17:36:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharmas-engagement-with-healthcare-providers-has-slipped-in-recent-years/ 2023-11-30T17:10:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-and-merck-backed-start-up-wins-10m-for-drug-and-device-development/ 2023-11-30T16:22:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cto-europe-2023-eus-ivd-guidelines-continue-affecting-early-clinical-work/ 2023-11-30T16:13:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/abuse-risk-non-stimulants-adhd/ 2023-11-30T16:02:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/generation-bio-cuts-40-of-staff-in-blow-for-non-viral-gene-therapy-sector/ 2023-12-01T15:03:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cyclin-dependent-kinase-4-cell-division-protein-kinase-4-or-psk-j3-or-cdk4-or-ec-2-7-11-22-drugs-in-development/ 2023-12-01T05:16:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-reinforces-amazon-partnership-for-faster-ai-led-drug-discovery-and-development/ 2023-11-30T14:15:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cto-europe-2023-fostering-diverse-oncology-trials-remains-a-challenge/ 2023-11-30T13:40:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/placenta-growth-factor-drugs-in-development/ 2024-10-01T03:19:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/myc-proto-oncogene-protein-drugs-in-development/ 2024-10-01T03:08:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bromodomain-containing-protein-4-drugs-in-development/ 2024-10-01T02:42:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nuclear-factor-erythroid-2-related-factor-2-drugs-in-development/ 2024-10-01T03:17:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/toll-llike-receptor-7-drugs-in-development/ 2024-10-01T03:48:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fibroblast-growth-factor-receptor-4-drugs-in-development/ 2024-10-01T02:53:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tyrosine-protein-kinase-fyn-drugs-in-development/ 2024-10-01T03:51:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/histone-deacetylase-6-drugs-in-development/ 2024-10-01T02:57:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alpha-synuclein-drugs-in-development/ 2024-10-01T02:29:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cop28-presidency-hails-loss-and-damage-fund-agreement-on-day-one/ 2023-11-29T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fourteen-financial-institutions-confirm-setup-abu-dhabi-uae/ 2023-11-29T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-opens-investigation-into-secondary-cancer-risk-with-car-t-therapies/ 2023-12-07T13:09:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-advances-small-molecule-drug-portfolio-with-prism-biolab-partnership/ 2023-11-29T16:50:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fda-nurown-treatement-als-discussion/ 2023-11-29T15:28:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cphi-barcelona-integration-atmp-manufacturing/ 2023-11-29T14:48:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/european-pharmaceutical-legislation-qa-hindrance-or-help/ 2023-12-14T01:29:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/candel-downsizes-to-focus-on-oncolytic-virus-based-cancer-therapies/ 2023-11-29T16:50:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cto-europe-2023-reflections-on-drug-development-through-the-phases/ 2023-11-29T12:14:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-to-manage-temperature-controlled-shipments-in-unpredictable-climate-zones/ 2024-02-06T12:18:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amacathera-non-opioid-therapy-development/ 2023-11-29T11:13:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aro-biotherapeutics-pompe-disease/ 2023-11-29T11:08:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/vpas-is-dead-long-live-vpag/ 2023-11-29T09:18:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharmas-path-to-net-zero-targeting-scope-3-emissions/ 2023-11-30T21:52:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/advanz-leverages-veeva-software-to-develop-hcp-platform/ 2023-12-01T15:35:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/avidity-bms-cardiovascular-targets/ 2023-11-29T09:05:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japan-approval-csl-arcturus-vaccine/ 2023-11-29T09:06:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vietnam-adopts-minimum-corporate-tax-for-foreign-companies/ 2023-11-28T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/acelyrin-claims-errors-by-cro-fortrea-led-to-late-stage-trial-downfall/ 2023-11-29T15:10:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayers-stock-drops-to-new-18-year-low-after-asundexian-trial-termination/ 2023-11-28T17:11:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cto-europe-2023-cancer-clinical-trials-shift-as-sector-goes-digital/ 2023-11-28T17:00:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emergent-wins-75m-barda-contact-for-anthrax-vaccine/ 2023-11-28T15:49:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novovaxs-omicron-targeting-covid-19-vaccine-obtains-who-emergency-listing/ 2023-11-29T21:16:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abeonas-cell-therapy-secures-priority-approval-date-for-rare-skin-disorder/ 2023-11-28T14:27:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/radiopharmaceuticals-reach-record-high-with-408m-in-venture-financing-for-2023/ 2023-11-28T13:32:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-rejects-aldeyras-dry-eye-drug-asks-for-more-clinical-data/ 2023-11-28T15:18:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-ibm-antibody-discovery/ 2023-11-28T11:07:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-orexo-nda/ 2023-11-28T10:56:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japan-daiichi-sankyo-covid-vaccine/ 2023-11-28T09:32:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-arcturus-cystic-fibrosis/ 2023-11-28T09:33:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ustekinumab-biosimilar-rani-therapeutics-net-present-value/ 2024-07-02T02:11:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/signal-british-biopharma-applies-for-bla-for-t-cell-cancer-therapy/ 2023-11-27T17:58:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-epcoritamab-gets-one-step-closer-to-follicular-lymphoma-approval/ 2023-11-27T15:39:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-fast-tracks-geneluxs-oncolytic-virus-based-ovarian-cancer-therapy/ 2023-11-27T14:54:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/clinical-monitoring-oversight-clinical-trials/ 2023-11-28T15:07:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-grants-second-orphan-drug-designation-to-priotheras-mocravimod/ 2023-11-27T14:49:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-and-regenerons-dupixent-scores-second-win-in-phase-iii-copd-trial/ 2023-11-27T14:26:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-eye-gels-microbial-contamination/ 2023-11-27T10:25:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-sandimmune-oral-solution-crystallisation/ 2023-11-27T10:11:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-wolman-disease-therapy/ 2023-11-27T09:17:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/everest-medicines-nmpa-igan-therapy/ 2023-11-27T08:13:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/translational-research-out-of-the-lab-into-the-clinic/ 2024-07-01T16:28:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-approves-jazzs-cannabis-derived-seizure-therapy/ 2023-11-24T15:45:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-expands-site-to-manufacture-glp-1-drugs/ 2023-11-24T14:43:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-expands-german-manufacturing-facilities-to-fulfill-supply-demand/ 2023-11-24T14:19:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sosei-to-regain-rights-to-ibd-drug-after-gsk-discontinues-programme/ 2023-11-24T11:23:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bristol-myers-squibb-patent-activity/ 2024-07-21T16:56:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/novartis-patent-activity/ 2024-07-21T16:57:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amgen-patent-activity/ 2024-07-21T16:56:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/johnson-johnson-patent-activity/ 2024-07-21T16:56:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/f-hoffmann-la-roche-patent-activity/ 2024-05-30T00:52:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lupin-vilfuro-g-india-copd/ 2023-11-24T10:39:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-approves-arkbio-rsv-antibody/ 2023-11-24T10:12:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertex-ec-combination-therapy-cf/ 2023-11-24T09:39:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ellipses-orphan-drug-designation-ret-inhibitor/ 2023-11-24T08:17:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/whats-in-a-name-agencies-struggle-to-keep-up-with-expanding-drug-space/ 2024-01-08T15:53:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-international-peers-more-strategic-in-attracting-fdi-says-lord-harrington-report/ 2023-11-23T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eirgenix-and-sandoz-win-eu-approval-for-herceptin-biosimilar/ 2023-11-23T14:59:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/simcere-and-connect-sign-licensing-agreement-for-anti-il-4r%ce%b1-ad-drug/ 2023-11-23T14:40:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-unveils-520m-for-life-sciences-as-part-of-autumn-statement-2023/ 2023-11-24T12:26:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-fast-tracks-alladapts-multi-food-allergy-immunotherapy/ 2023-11-23T14:08:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-benefits-of-using-an-app-to-manage-gestational-diabetes-nikis-story-2/ 2023-11-23T11:46:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-ingelheim-acquires-t3-pharma-for-509m/ 2023-11-23T11:44:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-anheart-innovent-lung-cancer-therapy/ 2023-11-23T11:08:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/syncona-biotechnology-company-freeline-therapeutics/ 2023-11-23T10:46:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sk-bioscience-ebola-vaccine/ 2023-11-23T09:33:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vivodyne-lab-grown-human-organs/ 2023-11-23T09:32:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merz-strengthens-its-global-footprint-with-botulinum-approval-in-australian-market/ 2023-11-22T21:11:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-senate-committee-calls-pharma-giants-for-another-hearing-on-drug-pricing/ 2023-11-22T15:52:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-issues-cipla-warning-letter-after-thousands-of-complaints/ 2023-11-22T15:38:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-mrna-patent-revoked-by-european-patent-office-after-pfizer-suit/ 2023-11-22T15:27:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lily-supports-alto-neuroscience-in-45m-series-c-round/ 2023-11-22T12:58:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/why-cop28-is-the-most-important-cop-since-the-paris-agreement/ 2023-11-22T13:27:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/igc-pharma-ai-drug-discovery/ 2023-11-22T11:28:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/myricx-licence-deal-wuxi-antibody/ 2023-11-22T11:30:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genentech-nvidia-drug-discovery-deal/ 2023-11-22T08:56:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sandoz-hyrimoz-europe/ 2023-11-22T08:27:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/valneva-files-patent-for-polypeptide-for-treating-or-preventing-borrelia-infection/ 2023-12-19T12:44:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rocket-pharmaceuticals-files-patent-for-gene-therapy-for-glut1-deficiency-syndrome-using-raav-vector/ 2023-12-05T13:31:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/4d-molecular-therapeutics-files-patent-for-the-patent-is-filed-for-a-modified-aav-virus-for-muscle-cell-infectivity/ 2023-12-19T12:43:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inozyme-pharma-files-patent-for-treatment-of-diseases-associated-with-enpp1-or-enpp3-deficiency/ 2023-12-05T13:29:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bolt-biotherapeutics-gets-grant-for-dectin-2-binding-agent-for-treating-diseases-in-mammals/ 2023-12-06T04:15:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/prelude-therapeutics-files-patent-for-heterocycle-cdk-inhibitors-and-their-pharmaceutical-compositions/ 2023-12-05T13:28:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/evelo-biosciences-files-patent-for-therapeutic-use-of-fournierella-massiliensis-bacteria/ 2023-12-19T12:43:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oric-pharmaceuticals-files-patent-for-method-of-treating-prostate-cancer-with-gr-antagonist-and-ar-degrader/ 2023-12-19T12:42:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ovid-therapeutics-gets-grant-for-treating-aural-fullness-or-hearing-loss-with-specific-compound/ 2023-12-06T04:11:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/denali-therapeutics-files-patent-for-crystalline-forms-of-a-specific-compound-and-their-preparation/ 2023-12-05T13:28:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abivax-gets-grant-for-patent-granted-for-compound-to-treat-rna-virus-infection/ 2023-12-06T04:09:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/voyager-therapeutics-files-patent-for-therapeutic-use-of-adeno-associated-virus-particles-for-disease-prevention-treatment/ 2023-12-19T12:41:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/agios-pharmaceuticals-files-patent-for-method-for-treating-lymphoma-using-anti-cancer-agent-and-therapy/ 2023-12-05T13:27:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gsk-gets-grant-for-inhibitors-of-dna-methyltransferase-1-activity-in-cancer-treatment/ 2023-12-06T04:08:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/radius-health-files-patent-for-analyzing-and-treating-abaloparatide-isomers-in-samples/ 2023-12-19T12:40:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zevra-therapeutics-files-patent-for-method-of-using-a-nk-antagonist-to-treat-vasomotor-symptoms-in-cancer-patients/ 2023-12-05T13:27:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eli-lilly-and-co-gets-grant-for-patent-granted-for-medication-delivery-device-with-dose-sensing/ 2023-12-06T04:07:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gilead-sciences-files-patent-for-treatment-of-viral-infections-using-a-non-coding-dna-sequence/ 2023-12-05T13:26:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jubilant-pharmova-files-patent-for-the-patent-filed-is-for-a-method-of-treating-netosis/ 2023-12-19T12:40:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/exelixis-files-patent-for-the-patent-is-filed-for-a-method-of-predicting-cancer-treatment-response/ 2023-12-19T12:39:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lonza-group-files-patent-for-method-for-reprogramming-mammalian-somatic-cells-using-synthetic-transcription-factors/ 2023-12-05T13:24:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/evotec-files-patent-for-novel-interferon-associated-antigen-binding-proteins-for-treating-hbv-infection/ 2023-12-05T13:23:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ardelyx-files-patent-for-method-for-generating-2d-intestinal-cell-cultures-without-cancer-cells/ 2023-12-19T12:39:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/actinium-pharmaceuticals-files-patent-for-the-patent-is-filed-for-compositions-and-methods-for-treating-cancers/ 2023-12-19T12:38:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/orexo-gets-grant-for-nasal-applicator-device-for-delivering-epinephrine-powder-to-nasal-mucosa/ 2023-12-06T04:03:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/argenx-files-patent-for-antibodies-for-inhibiting-tumor-cell-growth-by-binding-cd70/ 2023-12-05T13:22:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inflarx-files-patent-for-the-patent-filed-is-for-humanized-anti-c5a-antibodies/ 2023-12-05T13:18:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/takeda-pharmaceutical-files-patent-for-treating-schizophrenia-with-a-specific-compound-in-high-dosage/ 2023-12-19T12:36:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sorrento-therapeutics-gets-grant-for-variant-anti-ox40-antibody-for-enhancing-t-cell-expansion/ 2023-12-19T12:49:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/senju-pharmaceutical-gets-grant-for-medicament-for-treating-fuchs-endothelial-corneal-dystrophy-using-tgf-beta-signal-inhibiting-agent/ 2023-12-06T04:03:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sorrento-therapeutics-files-patent-for-method-for-treating-pulmonary-inflammatory-disease-by-neural-ablation/ 2023-12-19T12:35:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/omeros-files-patent-for-a-patent-filed-for-a-method-of-treating-autoimmune-disorders/ 2023-12-05T13:12:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/selecta-biosciences-gets-grant-for-patent-granted-for-a-method-of-administering-immunosuppressant-nanocarriers-with-antigen/ 2023-12-19T12:48:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/incyte-files-patent-for-method-for-reducing-itch-in-patients-with-atopic-dermatitis/ 2023-12-05T13:11:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anavex-life-sciences-files-patent-for-the-patent-is-filed-for-a-method-of-treating-seizures/ 2023-12-19T12:34:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ptc-therapeutics-gets-grant-for-patent-granted-for-pharmaceutical-composition-containing-crystalline-form-d-of-sepiapterin/ 2023-12-06T04:01:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amarin-corp-files-patent-for-method-of-reducing-triglycerides-in-a-subject-on-atorvastatin-therapy/ 2023-12-19T12:26:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/grunenthal-files-patent-for-method-of-treating-neuropathic-condition-with-high-concentration-capsaicin/ 2023-12-05T13:10:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/teladoc-health-gets-grant-for-remote-presence-interfaces-for-controlling-telepresence-devices-on-portable-electronic-devices/ 2023-12-19T12:48:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alnylam-pharmaceuticals-files-patent-for-antisense-polynucleotide-agent-for-inhibiting-angiotensinogen-expression/ 2023-12-19T12:25:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kineta-gets-grant-for-inhibition-of-usp14-for-treating-proteostasis-dysfunction/ 2023-12-06T04:00:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/faron-pharmaceuticals-files-patent-for-stable-formulation-of-anti-clever-1-antibody-for-disease-treatment/ 2023-12-05T13:09:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/spectrum-pharmaceuticals-files-patent-for-method-for-promoting-anti-tumor-immune-response-using-encapsulated-il-12/ 2023-12-19T12:23:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rigel-pharmaceuticals-files-patent-for-kinase-inhibitory-compounds-for-treating-rip1-associated-diseases/ 2023-12-05T13:08:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/les-laboratoires-servier-files-patent-for-anti-cd73-antibodies-for-treating-diseases-especially-cancer/ 2023-12-19T12:23:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/medigen-biotechnology-files-patent-for-the-patent-filed-is-for-monoclonal-antibodies-against-sars-cov-2/ 2023-12-05T13:07:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/blueprint-medicines-gets-grant-for-compound-for-treating-cancer/ 2023-12-19T12:47:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alector-files-patent-for-antibodies-for-preventing-or-treating-tmem106b-related-conditions/ 2023-12-19T12:22:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/blueprint-medicines-files-patent-for-crystalline-solid-form-of-compound-i-or-its-salt/ 2023-12-05T13:05:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kinnate-biopharma-files-patent-for-inhibitors-of-receptor-tyrosine-kinase-effector-for-disease-treatment/ 2023-12-05T13:04:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sword-health-files-patent-for-method-for-assessing-tracker-positions-on-a-person-s-body/ 2023-12-19T12:21:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dyne-therapeutics-files-patent-for-the-patent-is-filed-for-a-complex-that-promotes-dmd-gene-expression/ 2023-12-19T12:20:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sana-biotechnology-files-patent-for-a-binding-agent-for-treating-virus-infection-with-reduced-inflammation/ 2023-12-05T13:03:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/guangzhou-kingmed-diagnostics-group-files-patent-for-method-for-detecting-uniparental-disomy-using-ngs-trio-sequencing/ 2023-12-05T13:00:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innocare-pharma-files-patent-for-heterocyclic-compounds-as-immunomodulators-for-treating-diseases/ 2023-12-19T12:19:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kymera-therapeutics-files-patent-for-compounds-compositions-and-methods-of-using-the-same/ 2023-12-19T12:18:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/igm-biosciences-files-patent-for-modified-j-chain-antibodies-with-extraneous-binding-moiety/ 2023-12-05T12:59:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/celularity-files-patent-for-method-of-isolating-exosomes-from-placenta-or-portion-thereof/ 2023-12-05T12:57:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/springworks-therapeutics-files-patent-for-chlorinated-tetralin-compounds-and-pharmaceutical-compositions/ 2023-12-19T12:16:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ikena-oncology-files-patent-for-ahr-agonists-and-their-use-in-compositions-and-methods/ 2023-12-19T12:15:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wuxi-biologics-cayman-files-patent-for-genetically-modified-cell-line-producing-mannose-terminated-glycoprotein/ 2023-12-05T12:56:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cue-biopharma-files-patent-for-t-cell-modulatory-multimeric-polypeptides-with-variant-immunomodulatory-polypeptides/ 2023-12-05T12:55:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vir-biotechnology-files-patent-for-antibodies-for-neutralizing-hepatitis-b-and-hepatitis-d-infection/ 2023-12-19T12:14:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wuxi-apptec-files-patent-for-a-patent-for-a-process-of-producing-recombinant-adenoviral-particles/ 2023-12-19T12:13:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bolt-biotherapeutics-files-patent-for-immunoconjugates-for-cancer-treatment-using-elastase-substrate-peptide-linker/ 2023-12-05T12:54:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/c4-therapeutics-files-patent-for-compound-with-e3-ubiquitin-ligase-targeting-moieties-for-protein-degradation/ 2023-12-05T12:52:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aptinyx-files-patent-for-modulation-of-nmda-receptor-activity-for-treating-depression/ 2023-12-19T12:12:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lantern-pharma-files-patent-for-method-for-determining-cancer-sensitivity-to-illudin-or-illudin-analogs/ 2023-12-19T12:11:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ovid-therapeutics-files-patent-for-treatment-of-lennox-gastaut-syndrome-using-ganaxolone-oral-suspension/ 2023-12-05T12:50:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/revolution-medicines-files-patent-for-the-patent-is-filed-for-macrocyclic-compounds-inhibiting-ras-proteins/ 2023-12-05T12:51:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biora-therapeutics-files-patent-for-treating-gastrointestinal-diseases-with-a-tnf-alpha-inhibitor/ 2023-12-19T12:10:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anges-files-patent-for-patent-filed-for-a-non-naturally-occurring-crispr-nuclease-composition/ 2023-12-19T12:09:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/precision-biosciences-files-patent-for-mitochondria-targeting-engineered-meganuclease-for-modifying-human-mitochondrial-dna/ 2023-12-05T12:46:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kazakhstan-to-attract-150-billion-dollars-fdi-by-2029/ 2023-11-21T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/why-cop28-is-the-most-important-cop-since-the-paris-agreement-2/ 2023-11-21T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/experts-gene-therapy-potential-impact-gaucher-disease-market/ 2025-01-31T10:38:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-co-bolsters-neurogenerative-portfolio-with-caraway-acquisition/ 2023-11-21T15:52:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beigene-strikes-deal-worth-1-3bn-with-ensem-for-cdk2-inhibitor/ 2023-11-21T15:18:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-launches-medicines-scheme-with-400m-earmarked-for-clinical-trials/ 2023-11-21T14:04:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-delays-assessment-of-bms-and-2seventys-car-t-therapy/ 2023-11-22T10:30:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ascendis-parathyroid-hormone-replacement-therapy-wins-european-approval/ 2023-11-21T12:39:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-right-tools-how-in-house-tooling-streamlines-autoinjector-manufacturing/ 2023-11-21T11:34:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/texas-ag-sues-pfizer/ 2023-11-21T10:52:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mira-agreement-depression-therapy/ 2023-11-21T10:34:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zevra-acer-acquisition/ 2023-11-21T08:43:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-fda-lung-cancer-therapy/ 2023-11-21T08:22:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/are-haemophilia-gene-therapies-truly-one-and-done/ 2023-11-20T22:30:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-south-korea-21-billion-pounds-fdi/ 2023-11-20T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/neoimmunetech-bags-orphan-drug-tag-for-il-7-acute-radiation-syndrome-treatment/ 2023-11-20T20:13:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/wegovy-highlights-uks-complex-relationship-with-private-sector/ 2023-11-20T16:25:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chiesi-partners-with-haisco-to-commercialise-bronchiectasis-drug/ 2023-11-20T15:15:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-wins-eu-approval-for-paediatric-use-of-takhzyro-in-hae/ 2023-11-20T14:31:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oxurion-to-file-for-bankruptcy-following-trial-failure/ 2023-11-20T13:45:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-licenses-small-molecule-drug-delivery-technology-from-serina/ 2023-11-20T11:49:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/monash-university-prostate-cancer-therapy/ 2023-11-20T11:30:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-evinova-digital-health/ 2023-11-20T10:59:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-recall-vitrakvi-us/ 2023-11-20T09:06:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-approves-beigene-brukinsa/ 2023-11-20T08:28:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/antibody-drug-conjugates-targeted-therapies/ 2023-11-20T06:59:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hampton-court-palace-venue-chosen-global-investment-summit/ 2023-11-19T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/chatgpt-one-year-on-how-have-businesses-been-affected/ 2023-11-19T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mrna-3705-moderna-net-present-value/ 2024-05-16T02:00:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rpa-501-rocket-pharmaceuticals-net-present-value/ 2024-06-13T18:54:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pxvx-0317-bavarian-nordic-net-present-value/ 2024-12-13T02:53:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/diazoxide-choline-cr-soleno-therapeutics-net-present-value/ 2024-06-13T18:51:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/palazestrant-olema-pharmaceuticals-net-present-value/ 2024-05-16T02:08:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/reboxetine-axsome-therapeutics-net-present-value/ 2024-05-16T02:05:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tern-501-terns-pharmaceuticals-net-present-value/ 2024-12-13T02:50:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pirtobrutinib-eli-lilly-and-co-refractory-chronic-lymphocytic-leukemia-cll-likelihood-of-approval/ 2025-01-20T02:15:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pirtobrutinib-eli-lilly-and-co-relapsed-chronic-lymphocytic-leukemia-cll-likelihood-of-approval/ 2025-01-20T02:15:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/golexanolone-umecrine-cognition-hepatic-encephalopathy-likelihood-of-approval-2/ 2025-01-20T02:15:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glofitamab-f-hoffmann-la-roche-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2025-01-19T18:26:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kl-1333m-abliva-myoclonic-epilepsy-with-ragged-red-fibers-merrf-syndrome-likelihood-of-approval/ 2025-01-19T18:26:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/povetacicept-alpine-immune-sciences-idiopathic-thrombocytopenic-purpura-immune-thrombocytopenic-purpura-likelihood-of-approval-2/ 2024-12-25T17:58:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mrna-1083-moderna-influenza-a-virus-h3n2-subtype-infections-likelihood-of-approval-3/ 2025-01-19T18:08:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/mrna-1083-moderna-influenza-a-virus-h3n2-subtype-infections-likelihood-of-approval-2/ 2023-11-18T20:11:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mrna-1083-moderna-influenzavirus-b-infections-likelihood-of-approval-2/ 2025-01-19T18:08:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mrna-1083-moderna-influenza-a-virus-h1n1-subtype-infections-likelihood-of-approval-2/ 2025-01-19T18:08:08+00:00 daily 0.2